Wednesday, November 14, 2012
Print Entire 2012 Program:
|
|
SESSION 1 SCHEDULE | |
Wednesday
SESSION 1:
HEMODIALYSIS ACCESS - PART 1 (8-MINUTE TALKS)
Moderators:TBD
|
|
x | |
7:55 AM - 8:00 AM | Introduction |
Presenter(s):Larry A. Scher, MD / Thomas M. Vesely, MD | |
PART 1A: INTERVENTIONAL PROCEDURES FOR HEMODIALYSIS ACCESS (8-MINUTE TALKS) | |
Moderator(s): Larry A. Scher, MD / Thomas M. Vesely, MD | |
8:00 AM - 8:08 AM | Where Is The SVC/RA Junction And Why Is It Important In The Dialysis Patient |
Presenter(s):Jacob Cynamon, MD | |
8:09 AM - 8:17 AM | Access Survival After Prophylactic Angioplasty |
Presenter(s):Timothy A. Pflederer, MD | |
View Abstract | |
8:18 AM - 8:26 AM | Stent Grafts For Venous Anastomotic Stenosis |
Presenter(s):Thomas M. Vesely, MD | |
8:27 AM - 8:35 AM | Angioplasty, Stents Or Stent Grafts For Swing-Point Or Cephalic Arch Stenosis |
Presenter(s):Theodore F. Saad, MD | |
8:36 AM - 8:44 AM | Percutaneous Management Of The Non-Maturing Fistula |
Presenter(s):John E. Aruny, MD | |
8:45 AM - 8:53 AM | Blood Flow Measurement During Hemodialysis Access Procedures |
Presenter(s):Oleg Leontiev, MD | |
View Abstract | |
8:54 AM - 9:02 AM | Cardiovascular Implantable Device Guidelines In ESRD Patients |
Presenter(s):Haimanot (Monnie) Wasse, MD, MPH, FASN | |
9:03 AM - 9:11 AM | Endovascular Treatment Of Pacemaker Related Central Venous Stenosis |
Presenter(s):Dheeraj Rajan, MD, FRCPC | |
View Abstract | |
9:12 AM - 9:20 AM | Management Of SVC Syndrome And Complex Central Venous Stenosis |
Presenter(s):Richard J. Gray, MD, FSIR | |
9:21 AM - 9:29 AM | Radiofrequency Recanalization Of Central Venous Stenosis |
Presenter(s):Neil J. Halin, DO | |
9:30 AM - 9:50 AM | Panel Discussion |
9:50 AM - 10:15 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 1B: HEMODIALYSIS CATHETERS AND NEW TECHNOLOGY (8-MINUTE TALKS) | |
Moderator(s): Haimanot (Monnie) Wasse, MD, MPH, FASN / Theodore F. Saad, MD | |
10:15 AM - 10:23 AM | Uncommon Complications Of Hemodialysis Catheters |
Presenter(s):Kenneth D. Abreo, MD | |
View Abstract | |
10:24 AM - 10:32 AM | Inadvertent Arterial Catheterization During Central Venous Catheter Insertion |
Presenter(s):Tony P. Smith, MD | |
View Abstract | |
10:33 AM - 10:41 AM | Translumbar Hemodialysis Catheters |
Presenter(s):Gregory J. Nadolski, MD | |
View Abstract | |
10:42 AM - 10:50 AM | Balloon-Assisted Technique For The Placement Of The Outflow Segment Of The HeRO Device |
Presenter(s):Hector Ferral, MD | |
View Abstract | |
10:51 AM - 10:59 AM | Subclavian Vein Access: Over The Wire Graft Implantation Techniques With Hybrid Graft Technology |
Presenter(s):Stephen Settle, MD | |
View Abstract | |
11:00 AM - 11:08 AM | Computational Fluid Dynamics Of Hemodialysis Grafts |
Presenter(s):Christof Karmonik, PhD | |
11:09 AM - 11:17 AM | Vessel-Select Access System For Percutaneous AV Fistula Creation |
Presenter(s):Jeffrey E. Hull, MD | |
View Abstract | |
11:18 AM - 11:26 AM | Arteriovenous Fistula Creation Using The Optiflow Anastomotic Connector |
Presenter(s):Prabir Roy-Chaudhury, MD, PhD | |
11:27 AM - 11:35 AM | Blood Flow As Predictor Of Patency For Hemodialysis Access Procedures |
Presenter(s):Lars Lonn, MD, PhD | |
View Abstract | |
11:36 AM - 11:55 AM | Panel Discussion |
11:55 AM - 12:45 PM | Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 1 | |
SESSION 2 SCHEDULE | |
Wednesday
SESSION 2:
HEMODIALYSIS ACCESS - PART 2 (8-MINUTE TALKS)
Moderators:TBD
|
|
x | |
PART 2A: CLINICAL PRACTICE ISSUES I (8-MINUTE TALKS) | |
Moderator(s): Thomas M. Vesely, MD / Joseph N. Shams, MD | |
12:45 PM - 12:53 PM | Genetic Causation Of Hemodialysis Access Stenosis |
Presenter(s):Timmy Lee, MD, MSPH, FACP, FASN | |
12:54 PM - 1:02 PM | Mathematical Model Of Brachiocephalic Fistula: New Explanation For Success Of DRIL Procedure In Treating Hand Ischemia |
Presenter(s):William D. Paulson, MD | |
1:03 PM - 1:11 PM | The Effect Of Access Blood Flow On Cardiac Function |
Presenter(s):Louise Moist, MD, MSc | |
1:12 PM - 1:20 PM | Targeting Catheter Last In Fistula First |
Presenter(s):Joseph A. Vassalotti, MD | |
1:21 PM - 1:29 PM | Reducing Hemodialysis Catheters: When Is A Graft Preferred To Fistula? |
Presenter(s):Charmaine Lok, MD | |
1:30 PM - 1:38 PM | When Should Peritoneal Dialysis Be Considered? |
Presenter(s):Jack Work, MD | |
1:39 PM - 1:59 PM | Panel Discussion |
PART 2B: CLINICAL PRACTICE ISSUES II (8-MINUTE TALKS) | |
Moderator(s): Mitchell L. Henry, MD / Eric K. Peden, MD | |
2:00 PM - 2:08 PM | Bundling And Revaluing Hemodialysis Access Services |
Presenter(s):Sean P. Roddy, MD | |
2:09 PM - 2:17 PM | Accountable Access Care Organization |
Presenter(s):Timothy A. Pflederer, MD | |
View Abstract | |
2:18 PM - 2:26 PM | Fistula Maturation Is Related To Logistics, Communication, Training And Competency |
Presenter(s):Prabir Roy-Chaudhury, MD, PhD | |
2:27 PM - 2:35 PM | Training Surgeons To Perform Vascular Access |
Presenter(s):Mitchell L. Henry, MD | |
2:36 PM - 2:44 PM | Nursing Assessment And Management Of Access Related Aneurysms And Pseudoaneurysms |
Presenter(s):Brian LaMendola, RN, MBA | |
2:45 PM - 2:53 PM | Surgical Management Of Access Related Aneurysms And Pseudoaneurysm |
Presenter(s):Gary A. Gelbfish, MD | |
2:54 PM - 3:02 PM | Forearm Basilic Vein Transposition |
Presenter(s):Larry A. Scher, MD | |
3:03 PM - 3:25 PM | Panel Discussion |
3:25 PM - 3:45 PM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 2C: SURGICAL ISSUES IN HEMODIALYSIS ACCESS (8-MINUTE TALKS) | |
Moderator(s): Marc H. Glickman, MD / A. Frederick Schild, MD | |
3:45 PM - 3:53 PM | Can Early Cannulation Grafts Reduce Catheter Dependency? |
Presenter(s):Marc H. Glickman, MD | |
3:54 PM - 4:02 PM | Management Of Lower Extremity Steal Syndrome |
Presenter(s):Eric K. Peden, MD | |
4:03 PM - 4:11 PM | Endovascular And Surgical Options For Inflow Stenosis In Patients With Dysfunctional AV Access |
Presenter(s):Karl A. Illig, MD | |
4:12 PM - 4:20 PM | Options For Vascular Access In The Obese Patient |
Presenter(s):David L. Cull, MD, FACS | |
4:21 PM - 4:29 PM | Use Of A Bovine Carotid Artery For Hemodialysis Access |
Presenter(s):Eric K. Peden, MD | |
4:30 PM - 4:50 PM | Panel Discussion |
4:50 PM - 4:50 PM | Hemodialysis Access Program Adjourns. |
END OF SESSION 2 | |
SESSION 3 SCHEDULE | |
Wednesday
SESSION 3:
EMERGING MANAGEMENT OPTIONS FOR PULMONARY EMBOLISM
Moderators:Michael R. Jaff, DO
|
|
x | |
10:00 AM - 10:02 AM | Introduction To The Session |
Presenter(s):Frank J. Veith, MD | |
10:03 AM - 10:08 AM | Welcome And Introduction Of The Topic |
Presenter(s):Michael R. Jaff, DO | |
10:09 AM - 10:18 AM | What Must The Vascular Specialist Know About PE |
Presenter(s):Victor F. Tapson, MD | |
10:19 AM - 10:28 AM | Intravenous rtPA For Pulmonary Embolism: Does This Work |
Presenter(s):Ido Weinberg, MD, MSc | |
10:29 AM - 10:38 AM | Percutaneous Pharmacomechanical Intervention For PE: An Overview |
Presenter(s):Nils Kucher, MD | |
10:39 AM - 10:48 AM | The EKOS Strategy |
Presenter(s):Tod C. Engelhardt, MD | |
10:49 AM - 10:58 AM | The VORTEX Strategy |
Presenter(s):Christopher J. Kwolek, MD | |
10:59 AM - 11:08 AM | Angiojet Device To Treat Massive And Submassive PEs |
Presenter(s):Jeffrey Y. Wang, MD | |
View Abstract | |
11:09 AM - 11:18 AM | ECMO As The Bridge To Definitive Therapy For PE: Hybrid Approaches |
Presenter(s):Kenneth Rosenfield, MD | |
11:19 AM - 11:28 AM | Less May Be More: The Use Of Catheter Directed Thrombolysis In Conjunction With IVC Filters For Massive And Submassive PE |
Presenter(s):Gary M. Ansel, MD | |
11:29 AM - 11:38 AM | Techniques, Tips And Tricks For Endovascular Management Of Pulmonary Embolism |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
11:39 AM - 11:48 AM | Interventional Management Of Occlusive Iliofemoral Deep Venous Thrombosis: Another Evolution To A Revolution? |
Presenter(s):Mark H. Meissner, MD | |
11:49 AM - 12:00 PM | Panel Discussion/Questions And Answers |
12:00 PM - 1:00 PM | Lunch Break – Americas Hall 1 (3rd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 3 | |
SESSION 4 SCHEDULE | |
Wednesday
SESSION 4:
MANAGEMENT OF PROXIMAL VENOUS OBSTRUCTION
Moderators:Kenneth Ouriel, MD, MBA, FACS, FACC / Peter Gloviczki, MD
|
|
x | |
1:00 PM - 1:05 PM | Introduction To The Session |
Presenter(s):Kenneth Ouriel, MD, MBA, FACS, FACC / Frank J. Veith, MD | |
DEBATE: SHOULD ACUTE ISOLATED FEMOROPOPLITEAL DVT BE MANAGED AGGRESSIVELY | |
1:06 PM - 1:13 PM | Yes, Remove The Thrombus With Pharmacomechanical Means |
Presenter(s):Cynthia K. Shortell, MD | |
1:14 PM - 1:21 PM | No, Anticoagulation Alone Is Best |
Presenter(s):Thomas W. Wakefield, MD | |
1:22 PM - 1:30 PM | Discussion And Vote |
DEBATE: VENOUS THORACIC OUTLET SYNDROME: INTERVENTION OR OBSERVATION? | |
1:31 PM - 1:38 PM | Axillo-Subclavian Vein Thrombosis Should Be Treated With Early Thrombolysis, First Rib Resection And Open Venous Reconstruction |
Presenter(s):Karl A. Illig, MD | |
1:39 PM - 1:46 PM | There Is No Evidence That Intervention Is Better Than Anticoagulation For Acute Axillo-Subclavian Vein Thrombosis |
Presenter(s):Mark H. Meissner, MD | |
1:47 PM - 1:55 PM | Discussion And Vote |
DEBATE: HOW SHOULD WE MANAGE MAY-THURNER SYNDROME? | |
1:56 PM - 2:03 PM | May-Thurner Syndrome Should Be Treated Aggressively With Venous Stenting In All Symptomatic Patients |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
2:04 PM - 2:11 PM | Compression Treatment Alone Is Best For May-Thurner Syndrome |
Presenter(s):Gregory L. Moneta, MD | |
2:12 PM - 2:20 PM | Discussion And Vote |
DEBATE: THE BEST FIRST-LINE MODALITY FOR ILIOFEMORAL VENOUS THROMBUS IS . . . | |
2:21 PM - 2:28 PM | Open Surgical Thrombectomy Is The Standard |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
2:29 PM - 2:36 PM | Thrombolysis And Ultrasound Is Best |
Presenter(s):Mark J. Garcia, MD | |
2:37 PM - 2:45 PM | Discussion And Vote |
DEBATE: THE NUTCRACKER SYNDROME: WE CAN TREAT IT BUT SHOULD WE? | |
2:46 PM - 2:53 PM | Nutcracker Syndrome Is Best Managed By Open Surgical Reconstruction |
Presenter(s):Peter Gloviczki, MD | |
2:54 PM - 3:01 PM | Non-Aggressive Management Of Renal And Pelvic Venous Congestion Is Best |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
3:02 PM - 3:10 PM | Discussion And Vote |
3:11 PM - 3:15 PM | Summary And Conclusions |
Presenter(s):Peter Gloviczki, MD / Kenneth Ouriel, MD, MBA, FACS, FACC | |
3:15 PM - 3:15 PM | Adjourn. Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 4 | |
SESSION 5 SCHEDULE | |
Wednesday
SESSION 5:
ENDOVENOUS TREATMENT OF VARICOSE VEINS AND OTHER HOT VENOUS TOPICS - PART 1 (5-MINUTE TALKS)
|
|
x | |
8:00 AM - 8:06 AM | Welcome: Endovascular Venous Surgery At A Glance |
Presenter(s):Jose I. Almeida, MD, FACS, RVT | |
8:07 AM - 8:12 AM | Anatomy And Nomenclature Of The Venous System |
Presenter(s):Mark A. Adelman, MD | |
8:13 AM - 8:18 AM | Standards For Venous Mapping And Reflux Study |
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
8:19 AM - 8:24 AM | Clinical Evaluation Of The Venous Patient |
Presenter(s):Mark H. Meissner, MD | |
8:25 AM - 8:30 AM | Why Treat Varicose Veins: Is There Evidence? |
Presenter(s):Apostolos K. Tassiopoulos, MD | |
8:31 AM - 8:36 AM | How To Use CEAP And VCSS In Clinical Practice? |
Presenter(s):Michael A. Vasquez, MD, RVT | |
View Abstract | |
8:37 AM - 8:42 AM | Step-By Step Endovenous Thermal Ablation Of The GSV |
Presenter(s):Edward G. Mackay, MD | |
8:43 AM - 8:48 AM | Step-By Step Endovenous Thermal Ablation Of The SSV |
Presenter(s):Caron B. Rockman, MD | |
8:49 AM - 8:54 AM | Step-By Step Endovenous Chemical Ablation Of The GSV |
Presenter(s):Ted King, MD | |
8:55 AM - 9:00 AM | It Does Not Matter Which Device For Truncal Vein Ablation, The Results Are The Same |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
9:01 AM - 9:06 AM | Modern Day Stripping Is As Good As Endovenous Thermal Ablation |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
9:07 AM - 9:12 AM | Review Of Randomized Controlled Trials Comparing Endovenous Thermal And Chemical Ablation |
Presenter(s):Bo G. Eklof, MD, PhD | |
View Abstract | |
9:13 AM - 9:18 AM | Step-By Step: Ambulatory Phlebectomy |
Presenter(s):Paul Pittaluga, MD | |
9:19 AM - 9:24 AM | “Powered” Phlebectomy: Are We There Yet For Significant Branch Varicosities? |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
9:25 AM - 9:30 AM | Should Adjuvant Procedures Be Performed At The Same Time As Endovenous Thermal Ablation? Evidenced Based |
Presenter(s):Peter J. Pappas, MD | |
9:31 AM - 9:36 AM | Guidelines (USA vs UK) In The Management Of Superficial Venous Disease |
Presenter(s):Peter Gloviczki, MD | |
9:37 AM - 9:42 AM | Endovenous Thermal Ablation: Technical Pearls For Complex Anatomy |
Presenter(s):Jose I. Almeida, MD, FACS, RVT | |
9:43 AM - 9:48 AM | Update: Endovenous Laser Ablation |
Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
9:49 AM - 9:54 AM | When Is Prophylaxis Needed During GSV/SSV Ablation? |
Presenter(s):Caron B. Rockman, MD | |
9:55 AM - 10:00 AM | DEBATE: C2 Venous Disease Is Progressive: Its Treatment Should Be A Covered Insurance Benefit |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
10:01 AM - 10:06 AM | DEBATE: C2 Venous Disease Is Progressive: Its Treatment Should Not Be A Covered Insurance Benefit |
Presenter(s):Jose I. Almeida, MD, FACS, RVT | |
10:07 AM - 10:12 AM | Hurt Locker: Complications Of Endovenous Therapy |
Presenter(s):Renate R. van den Bos, MD, PhD | |
10:13 AM - 10:18 AM | Hurt Locker: Complications Of Foam And Liquid Sclerotherapy |
Presenter(s):Edward G. Mackay, MD | |
10:19 AM - 10:24 AM | Hurt Locker: Steps To Avoid Endothermal Heat Induced Thrombosis |
Presenter(s):Mikel Sadek, MD | |
10:25 AM - 10:30 AM | Hurt Locker: Steps To Avoid Saphenous And Sural Nerve Paresthesia |
Presenter(s):Jean Luc Gerard, MD | |
10:31 AM - 10:36 AM | Hurt Locker: Steps To Avoid Lymphatic Complications After Varicose Vein Surgery |
Presenter(s):Paul Pittaluga, MD | |
10:37 AM - 10:42 AM | Hurt Locker: Complications From The Treatment Of Klippel-Trenaunay Syndrome |
Presenter(s):Byung-Boong Lee, MD | |
View Abstract | |
10:43 AM - 10:48 AM | How To Differentiate Venous Ulcers From Others |
Presenter(s):Raghu Kolluri, MD | |
10:49 AM - 10:54 AM | Other Adjuncts To Heal Ulcers |
Presenter(s):William A. Marston, MD | |
10:55 AM - 11:00 AM | Reducing Venous Ulcers By 50% In 10 Years: The Next Steps |
Presenter(s):Peter Henke, MD | |
11:01 AM - 11:06 AM | Are We Really To Believe That Correction Of Saphenous Reflux Does Not Aid Ulcer Healing? Debunking The ESCHAR Trial |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
11:07 AM - 11:12 AM | DEBATE: Perforator Ablation Is Overused |
Presenter(s):Steve Elias, MD | |
11:13 AM - 11:18 AM | DEBATE: Perforator Ablation Is Not Overused |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
11:19 AM - 11:24 AM | Combined Treatment With Compression Therapy And Ablation Of Incompetent Superficial And Perforating Veins Reduces Ulcer Recurrence In Patients With CEAP 5 Venous Disease |
Presenter(s):Peter F. Lawrence, MD | |
11:25 AM - 11:30 AM | Update On Varicose Vein Recurrence: The REVATA Trial |
Presenter(s):Ronald G. Bush, MD | |
11:31 AM - 11:36 AM | Update On Commercially Available Foam Sclerotherapy: Results Of Phase 3 FDA Trial |
Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
11:37 AM - 12:00 PM | Panel Discussion |
Panelist(s): Jose I. Almeida, MD, FACS, RVT / Lowell S. Kabnick, MD, FACS, FACPh / Mark A. Adelman, MD / Michael C. Dalsing, MD / Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh / Peter Gloviczki, MD / William A. Marston, MD / Thomas F. O'Donnell, Jr., MD / Thomas W. Wakefield, MD / Cees H.A. Wittens, MD, PhD | |
12:00 PM - 1:00 PM | Lunch Break - Americas Hall 1, 3rd Floor Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 5 | |
SESSION 6 SCHEDULE | |
Wednesday
SESSION 6:
ENDOVENOUS TREATMENT OF VARICOSE VEINS AND OTHER HOT VENOUS TOPICS - PART 2 (5-MINUTE TALKS)
|
|
x | |
1:00 PM - 1:05 PM | Compression Therapy For Lymphatic Disease Treatment: Is That All There Is? |
Presenter(s):Raghu Kolluri, MD | |
1:06 PM - 1:11 PM | Compression: Should We Use Post Saphenous Ablation? Evidence? |
Presenter(s):Todd Berland, MD | |
1:12 PM - 1:17 PM | Compression: Medical Necessity Requirement Prior To Treatment: Really? Evidence? |
Presenter(s):Glenn Jacobowitz, MD | |
1:18 PM - 1:23 PM | Compression: Should We Use During Sports: Evidence? |
Presenter(s):Steve Elias, MD | |
1:24 PM - 1:29 PM | Introduction Of IACVC: Accreditation Of Vein Centers |
Presenter(s):John Blebea, MD, MBA | |
1:30 PM - 1:35 PM | If I Were To Build & Credential The “Ideal Vein Doctor” I Would Add These Ingredients . . . |
Presenter(s):Michael C. Dalsing, MD | |
1:36 PM - 1:41 PM | Misperceptions Of The American Board of Phlebology |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
1:42 PM - 1:47 PM | Update: Cyanoacrylate For GSV Ablation |
Presenter(s):Jose I. Almeida, MD, FACS, RVT | |
1:48 PM - 1:53 PM | Update: Mechanochemical GSV Ablation |
Presenter(s):Steve Elias, MD | |
1:54 PM - 1:59 PM | Should Endovenous Ablation Of Small Diameter Great Saphenous Veins Be Performed On Patients With Symptomatic Varicose Veins? |
Presenter(s):Alan M. Dietzek, MD, RPVI, FACS | |
2:00 PM - 2:05 PM | Update: Steam Ablation For GSV Ablation |
Presenter(s):Renate R. van den Bos, MD, PhD | |
2:06 PM - 2:11 PM | Can Venous Ablation Be Performed In Patients With A History Of Ipsilateral DVT? |
Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
2:12 PM - 2:17 PM | Where Will We Be In 2015? |
Presenter(s):Lowell S. Kabnick, MD, FACS, FACPh | |
2:18 PM - 2:23 PM | Present And Future Of Chronic Cerebrospinal Venous Insufficiency (CCVSI): Is This A Real Syndrome? |
Presenter(s):Mark H. Meissner, MD | |
2:24 PM - 2:29 PM | CCSVI: Our Results And Should We Continue To Treat? |
Presenter(s):Marzia Lugli, MD | |
2:30 PM - 2:35 PM | The Next Breakthrough In Venous Research? |
Presenter(s):Joseph D. Raffetto, MD | |
2:36 PM - 2:41 PM | Is Venous Disease Arterial? |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
2:42 PM - 2:47 PM | Implications Of Expanded Venous Reflux Study |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
2:48 PM - 2:53 PM | Detecting Iliac, IVC, Ovarian Vessels By Duplex Ultrasound |
Presenter(s):Judy M. Holdstock, DMU, DCR | |
2:54 PM - 2:59 PM | Pelvic Reflux With Or Without Pelvic Symptoms (C2 Or Higher): Should We Treat And How? |
Presenter(s):Mark S. Whiteley, MS, FRCS | |
3:00 PM - 3:05 PM | Best Imaging Techniques For Deep Venous Evaluation |
Presenter(s):Barry Stein, MD, FSIR, FACR | |
3:06 PM - 3:11 PM | What Is The Skinny On Caval Interruption? Overuse? |
Presenter(s):Robert B. McLafferty, MD | |
3:12 PM - 3:17 PM | Proposed Classification System For Iliocaval Occlusion |
Presenter(s):William A. Marston, MD | |
3:18 PM - 3:23 PM | Iliac Vein Stenting For Advanced Chronic Venous Disease: When Will It Improve Symptoms And When Will It Not? |
Presenter(s):Enrico Ascher, MD | |
3:24 PM - 3:29 PM | My Approach To Iliac Vein Outflow Occlusive Disease |
Presenter(s):Jose I. Almeida, MD, FACS, RVT | |
3:30 PM - 3:35 PM | Endovascular Treatment Of Chronic Venous Obstruction: Tips And Tricks Including Complete Obstruction |
Presenter(s):Mark J. Garcia, MD | |
View Abstract | |
3:36 PM - 3:41 PM | DEBATE: We Should Treat Intramuscular Calf Vein DVT With Standard Anticoagulation |
Presenter(s):Joann Lohr, MD | |
3:42 PM - 3:47 PM | DEBATE: We Should Not Treat Intramuscular Calf Vein DVT With Standard Anticoagulation |
Presenter(s):Clifford M. Sales, MD, MBA | |
3:48 PM - 3:53 PM | Superficial Venous Thrombophlebitis: To Treat Or Not To Treat? |
Presenter(s):Joseph D. Raffetto, MD | |
3:54 PM - 3:59 PM | 2012 Chest Guidelines - Important Changes |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
4:00 PM - 4:05 PM | Importance Of A Venous Registry And Opportunities In The Vascular Quality Initiative (SVS) |
Presenter(s):Jack L. Cronenwett, MD | |
4:06 PM - 4:11 PM | What Drugs Should We Be Using For DVT Treatment? |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
4:12 PM - 4:17 PM | Timing And Patient Selection For Thrombolysis |
Presenter(s):Antonios P. Gasparis, MD | |
4:18 PM - 4:23 PM | Should We Use The D-Dimer Test And/Or Residual Thrombus To Manage DVT? |
Presenter(s):Timothy K. Liem, MD | |
4:24 PM - 4:29 PM | Association Of Deep Vein Reflux And Obstruction In PTS: Which Is The Culprit? |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
4:30 PM - 4:35 PM | What Is A Saphenous Vein Aneurysm And How Should It Be Treated? |
Presenter(s):Ronald G. Bush, MD | |
4:36 PM - 4:41 PM | Mechanism Of Venous Valve Closure And The Role Of The Valve In Circulation |
Presenter(s):Fedor Lurie, MD, PhD | |
View Abstract | |
4:42 PM - 4:47 PM | Deep Venous Valvular Reconstruction: Indications, How And Results |
Presenter(s):Marzia Lugli, MD | |
4:48 PM - 4:53 PM | Natural History Of Advanced CVI (CEAP 4-6) Following Endovenous Ablation |
Presenter(s):Jennifer A. Heller, MD | |
4:54 PM - 5:15 PM | Panel Discussion |
Panelist(s): Jose I. Almeida, MD, FACS, RVT / Enrico Ascher, MD / Lowell S. Kabnick, MD, FACS, FACPh / Anthony J. Comerota, MD, FACS, FACC / Jack L. Cronenwett, MD / Alan M. Dietzek, MD, RPVI, FACS / Antonios P. Gasparis, MD / Marzia Lugli, MD / William A. Marston, MD / Mark H. Meissner, MD / Mark S. Whiteley, MS, FRCS | |
5:15 PM - 5:15 PM | ADJOURN |
END OF SESSION 6 | |
SESSION 7 SCHEDULE | |
Wednesday
SESSION 7:
WOUNDS - PART 1
Moderators:TBD
|
|
x | |
9:00 AM - 9:10 AM | Opening Remarks |
Presenter(s):Dieter O. Mayer, MD | |
PART 1A: NEW CONCEPTS IN WOUND CARE | |
Moderator(s): Giacomo Clerici, MD | |
9:10 AM - 9:20 AM | Utility Of V.A.C.® Therapy For Split-Thickness Skin Grafting |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
9:20 AM - 9:30 AM | Discussion |
9:30 AM - 9:40 AM | Topical Oxygen; Breathing New Life Into Chronic Wounds |
Presenter(s):Giacomo Clerici, MD | |
9:40 AM - 9:50 AM | Discussion |
9:50 AM - 10:00 AM | Diagnosis And Management Of Atypical Wounds Of The Lower Leg: An Update |
Presenter(s):Marco Romanelli, MD, PhD | |
10:00 AM - 10:10 AM | Discussion |
10:10 AM - 10:20 AM | A Systematic Approach To Surgical Debridement |
Presenter(s):Dieter O. Mayer, MD | |
10:20 AM - 10:30 AM | Discussion |
10:30 AM - 11:00 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 1B: FREE PAPER SESSION | |
Moderator(s): Dieter O. Mayer, MD | |
11:00 AM - 11:07 AM | Critical Limb Ischemia: Endovascular Below-The-Knee Maximal Revascularization Increases Wound Healing |
Presenter(s):Nirvana Sadaghianloo, MD | |
View Abstract | |
11:07 AM - 11:12 AM | Discussion |
11:12 AM - 11:19 AM | Maggot Therapy For Chronic Ulcer: Systematic Review, Meta-analysis And Cost-Effective |
Presenter(s):Chumpon Wilasrusmee, MD, MSc | |
11:19 AM - 11:24 AM | Discussion |
11:24 AM - 11:31 AM | A Novel Robotic Monofilament Test For Diabetic Neuropathy |
Presenter(s):Chumpon Wilasrusmee, MD, MSc | |
11:31 AM - 11:36 AM | Discussion |
11:36 AM - 11:43 AM | Can Audible Doppler Signal Be Used As An Alternative To Ankle Brachial Pressure Index |
Presenter(s):Afsaneh Alavi, MD, FRCPC | |
11:43 AM - 11:48 AM | Discussion |
11:48 AM - 11:55 AM | How Frequently Does A Malignant Wound Present As Leg Ulcer? |
Presenter(s):Afsaneh Alavi, MD, FRCPC | |
11:55 AM - 12:00 PM | Discussion |
12:00 PM - 12:30 PM | Lunch Break – Americas Hall 1, 3rd Floor Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 7 | |
SESSION 8 SCHEDULE | |
Wednesday
SESSION 8:
WOUNDS - PART 2
Moderators:TBD
|
|
x | |
PART 2A: EVIDENCE BASED MEDICINE IN WOUND CARE | |
Moderator(s): Bauer E. Sumpio, MD, PhD | |
12:30 PM - 12:40 PM | How To Implement EBM In Our Wound Clinic Or Surgical Department |
Presenter(s):Hester Vermeulen, PhD | |
View Abstract | |
12:40 PM - 12:50 PM | Delphi Studies In Wound Care Research: A New Better Tool For EBM? |
Presenter(s):Anne M. Eskes, RN, MSc | |
View Abstract | |
12:50 PM - 1:00 PM | How To Treat Donor Site Wounds: An Evidence Based Approach |
Presenter(s):Fleur E. Brolmann, MD | |
View Abstract | |
1:00 PM - 1:20 PM | Panel Discussion |
1:20 PM - 1:30 PM | The Association Of Ulceration Of The Foot With Cardiovascular And All-Cause Mortality In Patients With Diabetes: A Meta-Analysis |
Presenter(s):Robert J. Hinchliffe, MD | |
1:30 PM - 1:40 PM | Evidence Based Update: Diabetic Foot Ulcers And The Wound Bed Preparation Model |
Presenter(s):R. Gary Sibbald, MD | |
1:40 PM - 1:50 PM | Panel Discussion |
PART 2B: CONCEPTS FOR THE DIABETIC FOOT | |
Moderator(s): Giacomo Clerici, MD / Marc A. Brenner, DPM | |
1:50 PM - 2:10 PM | Facts That Every Vascular Surgeon Needs To Know About The Diabetic Foot |
Presenter(s):Michael E. Edmonds, MD | |
View Abstract | |
2:10 PM - 2:20 PM | Discussion |
2:20 PM - 2:40 PM | Foot Deformities In The Diabetic - More Than Charcot Foot |
Presenter(s):Thomas Boeni, MD | |
2:40 PM - 2:50 PM | Discussion |
2:50 PM - 3:00 PM | A New Device For Topical Intermittent Rapid Oxygenation – Compression To Increase Hyperoxygenated Blood Flow To The Horrendous Septic Diabetic Foot |
Presenter(s):Magdiel Trinidad-Vazquez, MD | |
View Abstract | |
3:00 PM - 3:10 PM | Discussion |
3:10 PM - 3:20 PM | Achilles Tendon Complete Tenotomy: THE Solution For Treating Neuropathic Diabetes Mellitus Foot Ulcers? |
Presenter(s):Wayne Caputo, DPM | |
3:20 PM - 3:30 PM | Discussion |
3:30 PM - 3:50 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 2C: VASCULAR INTERVENTIONS IN WOUND CAREK | |
Moderator(s): Joseph L. Mills, MD | |
3:50 PM - 4:00 PM | Peripheral VORTEC Procedures: Who Really Profits And Who Maybe Does Not? |
Presenter(s):Gabriel Szendro, MD | |
View Abstract | |
4:00 PM - 4:10 PM | Discussion |
4:10 PM - 4:20 PM | Provide Me An Inflow And I Will Heal Your Foot |
Presenter(s):Marc A. Brenner, DPM | |
4:20 PM - 4:30 PM | Discussion |
4:30 PM - 4:40 PM | Below-The-Knee Stent Or Balloon In Severe Critical Limb Ischemia With Extensive Wounds: Is It Worth The Effort |
Presenter(s):Sebastian E. Debus, MD, PhD | |
4:40 PM - 4:50 PM | Discussion |
4:50 PM - 5:00 PM | Is Tibial Angioplasty Effective To Improve Wound Healing In Patients With End- Stage Renal Disease (ESRD)? |
Presenter(s):Werner Lang, MD | |
5:00 PM - 5:10 PM | Discussion |
5:10 PM - 5:20 PM | Closing Remarks |
Presenter(s):Dieter O. Mayer, MD | |
5:20 PM - 5:20 PM | Adjourn |
END OF SESSION 8 | |
SESSION 9 SCHEDULE | |
Wednesday
SESSION 9:
MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 1
Moderators:TBD
|
|
x | |
7:55 AM - 8:00 AM | Welcome And Introduction |
Presenter(s):Allan L. Brook, MD | |
PART 1A: THE BASICS OF STROKE - INCLUDING THE EPIDEMIOLOGY AND NATURAL HISTORY | |
Moderator(s): Allan L. Brook, MD / Joshua A. Hirsch, MD | |
8:00 AM - 8:07 AM | Stroke: Where We Have Been And Now The 21st Century And things To Look Forward To |
Presenter(s):Lou Caplan, MD | |
8:08 AM - 8:16 AM | TIAs - What Is New: Diagnosis And When To Treat Aggressively |
Presenter(s):David S. Liebeskind, MD | |
8:17 AM - 8:25 AM | Brain Blood Flow - Physiology And Understanding The Basics: CBF, CBV, MTT: What Is Being Measured And What Matters The Most |
Presenter(s):Colin P. Derdeyn, MD | |
8:26 AM - 8:34 AM | Posterior Fossa: Why Do We Have A Longer Window? Or Do We Just Not Understand The Physiology? |
Presenter(s):Lou Caplan, MD | |
8:35 AM - 8:47 AM | The Clinical Exam: Quick Pearls That Tell You: Large Or Small Vessel Occlusion |
Presenter(s):Daniel L. Labovitz, MD | |
8:48 AM - 8:56 AM | Door To Revascularization Time: Optimization And Where Should We Be In 5 Years And Why |
Presenter(s):Edward C. Jauch, MD, MS | |
8:57 AM - 9:16 AM | Panel Discussion |
PART 1B: STATE-OF-THE-ART IMAGING | |
Moderator(s): Lawrence Wechsler, MD / David S. Liebeskind, MD | |
9:17 AM - 9:25 AM | Why Does Clot Location, Composition And Size Really Matter? |
Presenter(s):Albert J. Yoo, MD | |
9:26 AM - 9:34 AM | The Neuroimaging Protocol Made Easy: Quick, Accurate And Reliable Anatomic And Physiologic Imaging |
Presenter(s):Howard A. Rowley, MD | |
9:35 AM - 9:47 AM | Summarization Of The Latest Trials And Learning Points |
Presenter(s):Lawrence Wechsler, MD | |
9:48 AM - 9:56 AM | Collaterals And Definitive Reperfusion |
Presenter(s):David S. Liebeskind, MD | |
9:57 AM - 10:15 AM | Panel Discussion |
10:15 AM - 10:30 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 1C: TRIAGE ISSUES AND DEBATES | |
Moderator(s): Edward C. Jauch, MD, MS / Lawrence Wechsler, MD | |
10:31 AM - 10:38 AM | Triage At Its Best: My Brooklyn Pearls |
Presenter(s):Steven H. Rudolph, MD | |
10:39 AM - 10:46 AM | "Telestroke" 2012: From Far And Away The Specialist Can Make The Difference |
Presenter(s):Leonard Dimitri DaSilva, MD | |
10:47 AM - 10:53 AM | Why Has Imaging Failed To Find The Optimum Patients For Revascularization? |
Presenter(s):Lawrence Wechsler, MD | |
10:54 AM - 11:00 AM | Best Stroke Imaging Of The Future And Why |
Presenter(s):Pamela W. Schaefer, MD | |
PART 1D: ACUTE STROKE TREATMENT | |
Moderator(s): Peter A. Rasmussen, MD / Joshua A. Hirsch, MD | |
11:01 AM - 11:08 AM | IV TPA Recent Updated Guidelines: Does 3, 4, Or 6 Hours Really Have A Basis In The Literature Or In Pathophysiology? |
Presenter(s):Osama O. Zaidat, MD | |
11:08 AM - 11:16 AM | IA Medical Nuances - When And How Much: Does Temporary Stenting Revisit The Need For Thrombolytics |
Presenter(s):Don Frei, MD | |
11:17 AM - 11:23 AM | Thrombectomy: Summary Of The Clotted Data And Outcomes |
Presenter(s):Aquilla S. Turk, DO | |
11:24 AM - 11:31 AM | Antiplatelet Therapy And Beyond: How It Relates To Intracranial Stenting And More |
Presenter(s):Lucie G. Thibault, Pharm.D | |
11:32 AM - 11:39 AM | Angioplasty, Stenting And Temporary Stenting (A True Bridging Protocol): Facts And Fictions: My Opinion! |
Presenter(s):David Fiorella, MD | |
11:40 AM - 11:47 AM | Is It Device Or Patient Criteria That Are Most Important To Make An Impact In Early Revascularization With Efficacy? |
Presenter(s):Peter A. Rasmussen, MD | |
11:48 AM - 12:00 PM | Panel Discussion |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Wednesday
SESSION 10:
MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT - PART 2
Moderators:TBD
|
|
x | |
,B>PART 2A: LUNCHEON POWER SYMPOSIUM: CAROTID AND INTRACRANIAL STENTING: WHAT WENT WRONG WITH THE TRIALS? | |
Moderator(s): Thomas G. Brott, MD / Joshua A. Hirsch, MD / Peter K. Nelson, MD / Philip M. Meyers, MD | |
12:15 PM - 12:25 PM | CREST: Salient Points And Implications For The Future |
Presenter(s):Thomas G. Brott, MD | |
12:26 PM - 12:36 PM | Facts, Unknowns And Reasons For The Ongoing Controversy About The Best Treatment For Asymptomatic Carotid Stenosis |
Presenter(s):Frank J. Veith, MD | |
12:37 PM - 12:47 PM | Doppler Is Not Enough To Send My Patient For Revascularization And Why: The Neurological Perspective |
Presenter(s):Don Heck, MD | |
12:48 PM - 12:59 PM | Discussion |
1:00 PM - 1:10 PM | SAMMPRIS: Summary From The PI And Future Implications |
Presenter(s):Colin P. Derdeyn, MD | |
1:11 PM - 1:21 PM | SAMMPRIS Results: Why I Advocate A New Trial And Why Patients Need Technology |
Presenter(s):David Fiorella, MD | |
1:22 PM - 1:32 PM | IMS III – Latest Trial Results And Reason to Pause, Or Proceed With New Interest And Ideas: Unofficial Comments |
Presenter(s):Edward C. Jauch, MD, MS | |
1:33 PM - 1:43 PM | Stroke Trials: Lessons Learned: The Next Horizon To Make An Impact On Stroke Reversal Or Prevention |
Presenter(s):J Mocco, MD, MS | |
1:44 PM - 1:59 PM | Discussion |
PART 2B: THE OTHER SIDE OF STROKE: SUBARACHNOID HEMORRHAGE MANAGEMENT | |
Moderator(s): David Gordon, MD / Aquilla S. Turk, DO | |
2:00 PM - 2:10 PM | Subarachnoid Hemorrhage: Vasospasm Latest Developments |
Presenter(s):Aman B. Patel, MD | |
2:11 PM - 2:21 PM | Neuroanesthesia: Elements For Success |
Presenter(s):Apolonia E. Abramowicz, MD | |
View Abstract | |
2:22 PM - 2:32 PM | Latest Devices For Aneurysm Therapy: Are Coils Becoming The Second Option? |
Presenter(s):Peter K. Nelson, MD | |
2:33 PM - 2:43 PM | Surgical Clipping Of Aneurysms Is Still A Necessary Evil: Case Selection From An Experienced Cerebrovascular Neurosurgeon |
Presenter(s):Eugene S. Flamm, MD | |
2:44 PM - 2:54 PM | Endovascular Cases That Make Me Nervous: Location, Geometry, And Beyond |
Presenter(s):Aaron S. Dumont, MD | |
2:55 PM - 3:05 PM | Unruptured Aneurysms: Why Do We Treat Them? The US Experience vs. The Rest Of The World Opinion |
Presenter(s):Guilherme Dabus, MD | |
3:06 PM - 3:16 PM | Intracranial Bypass: Has A Dinosaur Come Back From Extinction? Best Indications And State-Of-The Art Techniques/NOVA |
Presenter(s):David J. Langer, MD | |
3:17 PM - 3:22 PM | Most Common Medical Legal Issues |
Presenter(s):Gregg H. Zoarski, MD | |
3:23 PM - 3:28 PM | Ways To Avoid Facing The Wrong Side Of The Jury |
Presenter(s):Michael I. Weintraub, MD | |
View Abstract | |
3:29 PM - 4:00 PM | Discussion |
4:00 PM - 4:00 PM | Adjourn. Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 10 | |
Thursday, November 15, 2012
Print Entire 2012 Program:
|
|
SESSION 11 SCHEDULE | |
Thursday
SESSION 11:
PROGRESS IN TRANSCATHETER HEART VALVES, NEW APPROACHES TO THE ASCENDING AORTA AND THORACIC AORTIC DISEASE (5-MINUTE TALKS)
|
|
x | |
6:30 AM - 6:35 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
6:35 AM - 6:40 AM | Transcatheter Aortic Valve Implantation (TAVI) For Unsatisfactory Surgical Valve Implantations: Will It Be An Exception Or The Routine In The Future |
Presenter(s):Dietmar H. Koschyk, MD | |
View Abstract | |
6:41 AM - 6:46 AM | Why Vascular Surgeons Must Play A Role In TAVI Procedures: Why Is Their Expertise Important |
Presenter(s):Marc R.H. van Sambeek, MD, PhD | |
View Abstract | |
6:47 AM - 6:52 AM | New Developments In Transcutaneous Mitral Valve Repair |
Presenter(s):Ted Feldman, MD | |
6:53 AM - 6:58 AM | Present Status And Future Potential Of TAVI |
Presenter(s):Martin B. Leon, MD | |
6:59 AM - 7:04 AM | Wrapping Procedure For Dilated Ascending Aorta: When And How To Do It |
Presenter(s):Mario Lachat, MD | |
7:05 AM - 7:10 AM | Status Of Endovascular Graft Repair For Aortic Arch Lesions: What Endovascular Solutions Are Working And What Are Not Working |
Presenter(s):Linda M. Reilly, MD / Timothy A.M. Chuter, DM | |
7:11 AM - 7:16 AM | Quantifying Ascending Aorta And Arch Deformation From Respiratory And Cardiac Motion: Implications For Branched Devices |
Presenter(s):Ronald L. Dalman, MD | |
7:17 AM - 7:22 AM | Retrograde Dissection During Endovascular Treatment Of Aortic Arch Pathology: How Can It Be Prevented And Treated |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
7:23 AM - 7:28 AM | Risk Factors Of Stroke In Thoracic Endovascular Aortic Repair (TEVAR) And How To Offset Them |
Presenter(s):Wei Guo Fu, MD | |
7:29 AM - 7:34 AM | Hybrid Rescue Techniques For Failed TEVAR Procedures |
Presenter(s):Eric E. Roselli, MD | |
7:35 AM - 7:41 AM | Panel Discussion |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Thursday
SESSION 12:
NEW DEVELOPMENTS IN TREATMENT OF THE ASCENDING AORTA, ARCH LESIONS AND AORTIC DISSECTIONS (5-MINUTE TALKS)
Moderators:Larry H. Hollier, MD / Richard P. Cambria, MD
|
|
x | |
7:41 AM - 7:46 AM | Future Of Endovascular Treatment Of Ascending Aortic Lesions |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
7:47 AM - 7:52 AM | Unusual Access Routes To The Ascending Aorta And Arch For Endograft Placement: Advantages, Limitations And Precautions |
Presenter(s):Tilo Koelbel, MD, PhD | |
7:53 AM - 7:58 AM | Experience With Endograft Treatment Of Ascending Aortic Lesions And Type A Dissections |
Presenter(s):Robert J. Hinchliffe, MD / Matt M. Thompson, MD | |
View Abstract | |
7:59 AM - 8:04 AM | Endovascular Graft Treatment Of Type A Dissections: Technique And In What Proportion Of Patients Will It Be Possible |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
8:05 AM - 8:10 AM | Complete Endovascular Graft Exclusion Of Arch Aneurysms Using A Non-Custom-Made Branched Arch Device (Cook) |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
8:11 AM - 8:16 AM | New Developments In Endovascular Repair Of Zone 0 Aortic Arch Pathologies |
Presenter(s):Toru Kuratani, MD, PhD | |
View Abstract | |
8:17 AM - 8:22 AM | Experience With The Bolton Arch Branch Endograft |
Presenter(s):W. Anthony Lee, MD | |
8:23 AM - 8:28 AM | Advantages Of A Precurved Fenestrated Endograft For Treating Arch Aneurysms And Dissections |
Presenter(s):Yoshihiko Yokoi, MD | |
View Abstract | |
8:29 AM - 8:34 AM | Hybrid (Open And Endo) Treatment Of Aortic Arch Aneurysms And Dissections: How Laparoscopy Can Help In Evaluating Patients With Malperfusion |
Presenter(s):Roberto Chiesa, MD | |
View Abstract | |
8:35 AM - 8:40 AM | Update On In Situ Fenestration For Arch Repair: Will Endovascular Total Arch Repair Replace Open Techniques |
Presenter(s):Bjõrn Sonesson, MD, PhD | |
View Abstract | |
8:41 AM - 8:47 AM | Panel Discussion |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Thursday
SESSION 13:
PROGRESS IN TREATING DISEASES OF THE THORACIC AORTA, INCLUDING DISSECTIONS AND MANAGING COMPLICATIONS (5-MINUTE TALKS)
Moderators:Ronald M. Fairman, MD / Christoph A. Nienaber, MD, PhD
|
|
x | |
8:47 AM - 8:52 AM | Open Surgical vs. Endovascular Treatment Of Thoracic Aortic Pathology In Marfan’s Syndrome: Is Endo Safe And When |
Presenter(s):Roberto Chiesa, MD | |
8:53 AM - 8:58 AM | TEVAR For Type B Aortic Dissections In Marfan’s Syndrome Can Work |
Presenter(s):Chang Shu, MD | |
View Abstract | |
8:59 AM - 9:04 AM | When Is TEVAR Contraindicated And Open Repair Needed With Thoracic Aortic Lesions |
Presenter(s):Michael J. Jacobs, MD | |
9:05 AM - 9:10 AM | What Is In And What Is Out With Type B Aortic Dissections And Their Endovascular Treatment |
Presenter(s):Zhong Gao Wang, MD | |
View Abstract | |
9:11 AM - 9:16 AM | Long-Term (5-Year) Data On Aortic Remodeling After TEVAR Treatment Of Type B Aortic Dissection Supports Early Intervention |
Presenter(s):Mark Conrad, MD / Richard P. Cambria, MD | |
9:17 AM - 9:22 AM | When Is TEVAR Inadequate Treatment For Type B Aortic Dissections |
Presenter(s):Götz M. Richter, MD, PhD | |
9:23 AM - 9:28 AM | DEBATE: Revascularization Of The Left Subclavian: When It Is Covered During TEVAR Matters: But Only With Aneurysms Not With Dissections |
Presenter(s):Robert J. Hinchliffe, MD / Matt M. Thompson, MD | |
View Abstract | |
9:29 AM - 9:34 AM | DEBATE: Revascularization Of The Left Subclavian: When It Is Covered During TEVAR Only Matters In Exceptional Circumstances |
Presenter(s):Thomas S. Maldonado, MD | |
9:35 AM - 9:40 AM | DEBATE: Routine Revascularization Of The Left Subclavian For All Zone 2 TEVARs Is Unnecessary And Probably Harmful |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
9:41 AM - 9:46 AM | Managing Progression Of Aortic Disease After TEVAR: Open Surgery Will Always Be Needed For Some Thoracic And Thoracoabdominal Aneurysms |
Presenter(s):Hazim J. Safi, MD | |
9:47 AM - 9:54 AM | Panel Discussion Conclusion of Program A |
9:54 AM - 10:11 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Thursday
SESSION 14:
LOWER EXTREMITY HOT TOPICS I (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Bruce J. Brener, MD
|
|
x | |
6:35 AM - 6:40 AM | Opening Remarks |
Presenter(s):Frank J. Veith, MD | |
6:40 AM - 6:45 AM | DEBATE: 2-3 Year Comparison Of Sirolimus Eluting Stents (SESs) vs. Bare Metal Stents (BMSs) For Below-Knee And Tibial Occlusive Disease (YUKON Trial) |
Presenter(s):Gunnar Tepe, MD | |
6:46 AM - 6:51 AM | DEBATE: Drug Eluting Balloons (DEBs) Are Better For Below-Knee Lesions Than SESs: 1-Year Results |
Presenter(s):Francesco Liistro, MD | |
6:52 AM - 6:57 AM | Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices |
Presenter(s):Koen Deloose, MD / Marc Bosiers, MD | |
View Abstract | |
6:58 AM - 7:03 AM | New Developments In Distal Puncture Techniques For Treating CTOs Of Lower Extremity Arteries: The Funnel Balloon Catheter; 3 Fr Sheath; Needle Extensions And COR Balloons |
Presenter(s):Andrej Schmidt, MD | |
7:04 AM - 7:09 AM | Best Treatment Of Popliteal Lesions: Stent vs. PTA: The ETAP Trial |
Presenter(s):Thomas Zeller, MD | |
7:10 AM - 7:15 AM | Value Of The Biodegradable Balloon Expandable Remedy Stent For Lower Extremity Lesions: The GAIA Trial Results |
Presenter(s):Dierk Scheinert, MD | |
7:16 AM - 7:21 AM | Does Atherectomy Help To Treat Resistant Calcified SFA Lesions: Does It Require A Distal Filter For Safety |
Presenter(s):Daniel G. Clair, MD | |
7:22 AM - 7:27 AM | DEBATE: Current Role Of New Atherectomy Devices: They Work And Justify The Costs |
Presenter(s):James F. McKinsey, MD | |
7:28 AM - 7:33 AM | DEBATE: Debulking With Atherectomy And Laser Is A Good Idea Whose Time Has Passed |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
7:34 AM - 7:40 AM | Panel Discussion |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
Thursday
SESSION 15:
LOWER EXTREMITY HOT TOPICS II (5-MINUTE TALKS)
Moderators:Kenneth Ouriel, MD, MBA, FACS, FACC / Evan C. Lipsitz, MD
|
|
x | |
7:40 AM - 7:45 AM | Long-Term Evaluation (To 5 Years) Of SFA Stents In 1000 Patients: Importance Of TASC Classification, Stent Type And Lesion Length (Belgian/German Study) |
Presenter(s):Marc Bosiers, MD / Giovanni Torsello, MD / Patrick Peeters, MD | |
7:46 AM - 7:51 AM | The Many Uses And Advantages Of The Supera Veritas Stent (IDEV) To Treat Femoropopliteal Lesions |
Presenter(s):Peter C.J. Goverde, MD / Dierk Scheinert, MD | |
7:52 AM - 7:57 AM | 1-Year Results Of The Protege Everflex Stent (ev3) To Treat Popliteal Lesions: DURABILITY-POP Study |
Presenter(s):Patrick Peeters, MD | |
7:58 AM - 8:03 AM | DEBATE: CFA And DFA Occlusive Lesions Are Best Treated By Endovascular Techniques |
Presenter(s):Thomas Zeller, MD | |
8:04 AM - 8:09 AM | DEBATE: How Should CFA And DFA Occlusive Lesions Best Be Treated |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
8:10 AM - 8:15 AM | Extreme Approaches To CTOs via Retrograde Puncture Of Pedal Loop And Digital Arteries: How To Do It |
Presenter(s):Marco G. Manzi, MD | |
8:16 AM - 8:21 AM | DEBATE: Stenting Is Still First Line Treatment For SFA Occlusive Disease |
Presenter(s):Erich Minar, MD | |
8:22 AM - 8:27 AM | DEBATE: Why Should Metal Be Avoided In The SFA And How To Do It |
Presenter(s):Giancarlo Biamino, MD, PhD | |
8:28 AM - 8:33 AM | How To Remove Small Procedural Emboli From Tibial Arteries |
Presenter(s):Andrej Schmidt, MD | |
8:34 AM - 8:39 AM | What To Do For CLI Patients When There Are No Patent Outflow Arteries: Can DEBs Help |
Presenter(s):Roberto Ferraresi, MD | |
8:40 AM - 8:46 AM | Panel Discussion |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
Thursday
SESSION 16:
LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS)
Moderators:Jacques Busquet, MD / Luis A. Sanchez, MD
|
|
x | |
8:46 AM - 8:51 AM | DEBATE: Atherectomy And DEBs For Native Disease And In Stent Restenosis In The SFA And Popliteal: Stents Can Be Avoided Completely |
Presenter(s):Thomas Zeller, MD | |
8:52 AM - 8:57 AM | DEBATE: DEBs Won’t Do The Job Alone: Stents Will Be Needed Sometimes For Recoil Or Dissection |
Presenter(s):Dierk Scheinert, MD | |
8:58 AM - 9:03 AM | The Tack-It Device: An Endovascular Stapler For Imperfect PTAs To Avoid Stenting |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
9:04 AM - 9:09 AM | 3-Year Results Of The RESILIENT Trial With The Lifestent: Are The Results Of SFA Stents Durable |
Presenter(s):John R. Laird, MD | |
9:10 AM - 9:15 AM | 3-Year Results From The ZILVER PTX Drug Eluting Stent (DES) Trial: Are The Results Durable And How Do Patterns Of Restenosis Differ |
Presenter(s):Michael D. Dake, MD / Gary M. Ansel, MD | |
9:16 AM - 9:21 AM | 2-Year Outcomes Of Stent Supported PTA For Iliac Lesions: Balloon vs. Self-Expanding Stents: Influence Of TASC Classification: The BRAVISSIMO Trial |
Presenter(s):Patrick Peeters, MD | |
9:22 AM - 9:27 AM | DEBATE: To Treat Lower Extremity Chronic Total Occlusions (CTOs) One Only Needs A Wire And A Catheter And Not All This Expensive Nonsense |
Presenter(s):Amman Bolia, MD | |
View Abstract | |
9:28 AM - 9:33 AM | DEBATE: We Need All This Stuff And More To Meet Unmet Needs With Lower Extremity Occlusive Disease |
Presenter(s):Gary M. Ansel, MD | |
9:34 AM - 9:39 AM | How To Use A Radiofrequency Wire To Cross Difficult CTOs: Advantages, Precautions, Limitations |
Presenter(s):Marcelo S. Guimaraes, MD | |
9:40 AM - 9:45 AM | ALL CLI Is Not The Same: This And Diabetic Status Render Limb Salvage Rates A Poor Index Of Success With Revascularization Procedures: Some Limbs With CLI Survive With Conservative Treatment And Prayer |
Presenter(s):Francesco Serino, MD | |
9:46 AM - 9:54 AM | Panel Discussion Conclusion of Joint Sessions with VEITHsymposium. VEITHsymposium continues after the Break in the Grand Ballroom, 3rd Floor. AIMsymposium continues at 10:00 a.m. |
9:54 AM - 10:10 AM | Break - Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Thursday
SESSION 17:
NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENT AND MANAGEMENT OF CRITICAL LIMB ISCHEMIA (CLI) (5-MINUTE TALKS)
Moderators:Frank J. Veith, MD / Barry T. Katzen, MD
|
|
x | |
10:10 AM - 10:15 AM | Why Is Duplex For Guidance For Lower Extremity Endovascular Procedures Not Replacing Fluoroscopy: Duplex Is So Much Better |
Presenter(s):Enrico Ascher, MD | |
10:16 AM - 10:21 AM | 13 Steps To Successful Pedal Access |
Presenter(s):Craig M. Walker, MD | |
10:22 AM - 10:27 AM | Drug Eluting Balloons (DEBs) Really Work: Comparative Results Prove It: When And Where Are DEBs Indicated |
Presenter(s):Gunnar Tepe, MD | |
10:28 AM - 10:33 AM | How Have DEBs Changed Lower Extremity Interventional Practice In Germany: Above And Below The Knee |
Presenter(s):Andrej Schmidt, MD | |
10:34 AM - 10:39 AM | How DEBs Have Changed Lower Extremity Interventional Practice In Italy: Are They Worth The Increased Cost |
Presenter(s):Giancarlo Biamino, MD, PhD | |
10:40 AM - 10:45 AM | Drug-Eluting Stents For Focal Infrapopliteal Lesions: Meta-analysis Of The ACHILLES, DESTINY And YUKON-BTX Trials |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Abstract | |
10:46 AM - 10:51 AM | Differences In Amputation Rates Following Treatment For Tissue Loss (Gangrene) And Rest Pain: Their Importance In Trials Evaluating Stem Cell And Other New Treatments |
Presenter(s):Thomas F. O'Donnell, Jr., MD | |
View Abstract | |
10:52 AM - 10:57 AM | Why Are DESs Not Going To Work In CLI Patients Based On The Anatomy Of Their Lesions |
Presenter(s):Nicolas A. Diehm, MD | |
10:58 AM - 11:03 AM | The Case For Subintimal PTA Above And Below The Inguinal Ligament |
Presenter(s):George H. Meier III, MD | |
11:04 AM - 11:09 AM | Open Bypass Procedures Have Value And Can Work When Endovascular Interventions Have Failed: What Percentage Of CLI Patients Will Need A Bypass: Endo First Is Not The Way To Go In Some Patients Since Bridges Are Burned |
Presenter(s):Francesco Spinelli, MD | |
View Abstract | |
11:10 AM - 11:15 AM | Pedal Bypasses Are Definitely Superior To PTA For Long Tibial Lesions |
Presenter(s):Werner Lang, MD | |
11:16 AM - 11:21 AM | Wound Related And Flow Guided Treatment For CLI With Necrotic Foot Lesions |
Presenter(s):Roberto Ferraresi, MD | |
11:22 AM - 11:27 AM | DEBATE: The Case For The Angiosome Concept |
Presenter(s):Richard F. Neville, MD | |
11:28 AM - 11:33 AM | DEBATE: The Angiosome Concept Is Not Important Except Possibly In Dialysis Patients |
Presenter(s):Nobuyoshi Azuma, MD | |
View Abstract | |
11:34 AM - 11:39 AM | DEBATE: A Patent Pedal Arch Is More Important Than The Angiosome Concept: But Foot Healing Can Occur Without An Intact Pedal Arch |
Presenter(s):Hisham Rashid, MSc, FRCS, FRCS(Gen) | |
View Abstract | |
11:40 AM - 11:45 AM | Indocyanine Green Angiography: A Method To Study The Angiosome Concept |
Presenter(s):Joseph L. Mills, MD | |
11:46 AM - 11:51 AM | Stem Cell Therapy Will Have An Increasing Role In The Treatment Of CLI: It Really Works And A Glimpse Into The Future: Based On The RESTORE CLI Phase 2b Trial |
Presenter(s):Richard J. Powell, MD | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Americas Hall I, 3rd Floor Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
Thursday
SESSION 18:
NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
Moderators:Juan C. Parodi, MD / Hazim J. Safi, MD
|
|
x | |
1:00 PM - 1:05 PM | Axillofemoral Bypass To Prevent Limb Ischemia During Prolonged Iliac Sheath Occlusion For Complex EVARs |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
1:06 PM - 1:11 PM | Lessons Learned And Precautions Needed With Fenestrated And Branched Grafts For Complex Aneurysm Repairs |
Presenter(s):Piotr M. Kasprzak, MD | |
1:12 PM - 1:17 PM | Pathogenesis Of Spinal Cord Ischemia (SCI) During TEVAR And Open Repair: Is It The Same Or Different: Implications For Prevention And Treatment |
Presenter(s):Charles W. Acher, MD | |
1:18 PM - 1:23 PM | How To Prevent SCI After TEVAR |
Presenter(s):Michael J. Jacobs, MD | |
1:24 PM - 1:29 PM | Tips And Tricks For Performing CSF Drainage Optimally With TEVAR Or Open Repair |
Presenter(s):Vicente Riambau, MD, PhD | |
View Abstract | |
1:30 PM - 1:35 PM | DEBATE: Endovascular Graft Treatment Of Acute Uncomplicated Type B Aortic Dissection May Not Be A Good Idea: Medical Treatment May Be As Good (Video) |
Presenter(s):Sebastian E. Debus, MD, PhD | |
1:36 PM - 1:41 PM | DEBATE: Experience With Early TEVAR Treatment Of Uncomplicated Type B Aortic Dissection: It Really Is The Right Thing To Do Based On False Lumen/True Lumen Measurements |
Presenter(s):Rodney A. White, MD | |
1:42 PM - 1:47 PM | Long-Term (3-5 Year) Results Of The INSTEAD Trial Shows The Benefit Of Early TEVAR Treatment Of Uncomplicated Type B Aortic Dissections: Game Changing Results |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
1:48 PM - 1:53 PM | Results Of TEVAR In Acute Type B Aortic Dissection vs. Best Medical Treatment: First Results Of The ADSORB Trial: A Randomized Controlled Trial |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
1:54 PM - 1:59 PM | Some Concerns After Aortic Endografting For Type B Aortic Dissections |
Presenter(s):Stephen W.K. Cheng, MBBS | |
2:00 PM - 2:05 PM | How Valuable Are The Aptus HeliFX Staples (EndoAnchors): Results From The ANCHOR Registry |
Presenter(s):William D. Jordan, Jr., MD | |
View Abstract | |
2:06 PM - 2:12 PM | Panel Discussion |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Thursday
SESSION 19:
CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2012: WHERE IS IT AND WHERE IS IT GOING
Moderators:Giorgio M. Biasi, MD / Frank J. Veith, MD
|
|
x | |
2:12 PM - 2:17 PM | Why MRI Should Be Done Before All Revascularization Procedures (CAS And CEA): Duplex Is Not Enough |
Presenter(s):Emmanuel M. Houdart, MD | |
2:18 PM - 2:23 PM | Closed vs. Open Cell Stents For CAS: The Number Of Embolic Particles Are No Greater Nor Are Outcomes Worse With Open Cell Stents |
Presenter(s):Peter L. Faries, MD, FACS | |
2:24 PM - 2:29 PM | CAS For Total Carotid Occlusion: It Can Work And Be Beneficial: Under What Circumstances |
Presenter(s):Paul H.L. Kao, MD | |
2:30 PM - 2:35 PM | DEBATE: CAS Is Good Treatment For Most Patients With Symptomatic And Asymptomatic Carotid Stenosis |
Presenter(s):Klaus D. Mathias, MD | |
2:36 PM - 2:41 AM | DEBATE: CAS Is Not Good Treatment For Most Patients With Symptomatic And Asymptomatic Carotid Stenosis |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
2:42 PM - 2:47 PM | Is Current Best Medical Treatment (BMT) Feasible And Does It Work To Decrease Strokes From Intracranial Disease In A High Risk Population: Results From The SAMMPRIS Trial Suggest BMT Can Decrease Strokes Markedly |
Presenter(s):Marc Chimowitz, MD | |
2:48 PM - 2:53 PM | Analysis Of CREST By A Neuroradiologist: What Is The Significance Of A Minor Stroke |
Presenter(s):Emmanuel M. Houdart, MD | |
2:54 PM - 2:59 PM | DEBATE: Cardiac Events Are An Appropriate End-Point For Evaluating CAS vs. CEA Outcomes; And In CREST, CAS Results Improved With Time |
Presenter(s):William A. Gray, MD | |
3:00 PM - 3:05 PM | DEBATE: Cardiac Events Are Not An Appropriate End-Point For Evaluating CAS vs. CEA Outcomes; And In CREST, CAS Results Did Not Improve With Time |
Presenter(s):Wesley S. Moore, MD | |
View Abstract | |
3:06 PM - 3:11 PM | Interventions Performed Within 1 Week Of A Neurological Event: Outcomes Of CEA Are Better Than CAS |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
3:12 PM - 3:17 PM | The Case Against Embolic Protection Devices In CAS: Why Therefore Are They So Widely Used |
Presenter(s):Michel S. Makaroun, MD | |
3:18 PM - 3:23 PM | Meta-Analysis Of CAS By Cervical Access Shows Dramatic Reduction In Neurological Events |
Presenter(s):Patrice F. Bergeron, MD / Petrosian Andranik, MD | |
3:24 PM - 3:29 PM | A Specialized Device For Performing CAS Via A Cervical Approach With Flow Reversal (FAST-CAS System): Early Results From The PROOF Trial |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
3:30 PM - 3:35 PM | DEBATE: Why Is It Difficult To Randomize Asymptomatic Carotid Stenosis Patients To A 3-Armed Trial: CEA vs. CAS vs. BMT |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
3:36 PM - 3:41 PM | DEBATE:Why We Must Have A Trial Comparing BMT To CAS And CEA In Asymptomatic Patients With Carotid Stenosis |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP, FRACP | |
View Abstract | |
3:42 PM - 3:47 PM | TCD Embolic Signals, Silent Infarcts On CT-Brain Scans, Or The Size Of Juxtaluminal Black Area In Evaluating Stroke Potential Of Asymptomatic Carotid Lesions |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Abstract | |
3:48 PM - 4:00 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Thursday
SESSION 20:
NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS (5-MINUTE TALKS)
Moderators:Mark A. Adelman, MD / Darren B. Schneider, MD
|
|
x | |
4:00 PM - 4:05 PM | Patency Of Viabahn Stent Grafts Is Better Than Bare Metal Stents For SFA Occlusive Disease: Final Results Of The VIASTAR Trial |
Presenter(s):Johannes Lammer, MD | |
4:06 PM - 4:11 PM | Are Stent Grafts The Solution For In-Stent Restenosis After SFA Stenting |
Presenter(s):Marc Bosiers, MD / Koen Deloose, MD | |
View Abstract | |
4:12 PM - 4:17 PM | Technical Considerations To Improve Results With SFA Stent-Grafting For Occlusive Disease: Lessons Learned From The VIPER Trial With Heparin-Bonded Viabahn Stent-Grafts |
Presenter(s):Richard R. Saxon, MD | |
View Abstract | |
4:18 PM - 4:23 PM | Why Do Viabahn Stent-Grafts Fail In The First Year: Does Collateral Coverage And Antiplatelet Treatment Matter |
Presenter(s):Michael S. Conte, MD | |
4:24 PM - 4:29 PM | Standard Fempop Bypasses Are Better Than Endoluminal Stent-Graft “Bypasses” For 5-25 cm SFA Occlusions: An Older RCT: Is It Still Relevant |
Presenter(s):Mauri J.A. Lepantalo, MD | |
View Abstract | |
4:30 PM - 4:35 PM | Current Status Of Heparin Bonded Viabahn Stent-Grafts Based On European Studies |
Presenter(s):Thomas Zeller, MD | |
4:36 PM - 4:41 PM | Current Status Of Viabahn Endografts For Treatment Of Popliteal Aneurysms: Which Patients Should Not Be Treated Endovascularly |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
4:42 PM - 4:47 PM | Can Covered Stents Safely Be Placed Across The Inguinal Ligament And In The CFA |
Presenter(s):Keith D. Calligaro, MD | |
View Abstract | |
4:48 PM - 4:55 PM | Panel Discussion |
END OF SESSION 20 | |
SESSION 21 SCHEDULE | |
Thursday
SESSION 21:
NEW OR IMPROVED CONCEPTS IN VASCULAR DISEASE TREATMENT AND THE CONTROVERSY OVER THE INTERVENTIONAL TREATMENT OF CCSVI FOR MULTIPLE SCLEROSIS (5-MINUTE TALKS)
Moderators:Bruce A. Perler, MD, MBA / Jean-Baptiste Ricco, MD, PhD
|
|
x | |
4:55 PM - 5:00 PM | Tips And Tricks For Vascular Disease Intervention In Pediatric Patients |
Presenter(s):Furuzan Numan, MD | |
5:01 PM - 5:06 PM | DEBATE: Update On The Treatment Of Vasculogenic Impotence: Viagra, Cialis And Levitra Are Most Often Enough |
Presenter(s):Ralph G. DePalma, MD | |
View Abstract | |
5:07 PM - 5:12 PM | DEBATE: Not True, Some Patients Need Internal Pudendal Stenting: Current Status Of The Endovascular Treatment Of Erectile Dysfunction |
Presenter(s):Krishna J. Rocha-Singh, MD | |
View Abstract | |
THE CCSVI CONTROVERSY IN MULTIPLE SCLEROSIS | |
5:13 PM - 5:18 PM | What’s New In The Diagnosis And Endovascular Treatment Of CCSVI In MS Patients |
Presenter(s):Paolo Zamboni, MD | |
5:19 PM - 5:24 PM | Endovascular Treatment Of CCSVI In MS Patients Really Works: The Benefits Of Treating Venous Brain Congestion Can Be Documented |
Presenter(s):Ivo Petrov, MD, PhD | |
5:25 PM - 5:30 PM | Does Interventional Treatment Help MS Patients: A Skeptical Vascular Surgeon Remains Skeptical |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
5:31 PM - 5:36 PM | Intrinsic And Extrinsic Cerebrospinal Venous Abnormalities In Neurological Diseases: Anatomic And Physiological Evidence |
Presenter(s):Michael D. Dake, MD | |
5:37 PM - 5:42 PM | Interventional Treatment Of CCSVI Can Improve MS: A Vascular Surgeon Who Is Convinced |
Presenter(s):Manish Mehta, MD, MPH | |
5:43 PM - 5:48 PM | DEBATE: The Case Against Treating CCSVI In MS Patients |
Presenter(s):Emmanuel M. Houdart, MD | |
5:49 PM - 5:54 PM | DEBATE: The Case For Treating CCSVI In MS Patients |
Presenter(s):Donald B. Reid, MD | |
5:55 PM - 6:00 PM | DEBATE: Venous Angioplasty For MS Is Voodoo Medicine |
Presenter(s):Mark H. Wholey, MD | |
6:01 PM - 6:06 PM | Panel Discussion |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Thursday
SESSION 22:
NEW OR BETTER TECHNIQUES FOR TREATING ENDOLEAKS AND OTHER EVAR AND TEVAR TOPICS (5-MINUTE TALKS)
Moderators:Timur P. Sarac, MD / Luis A. Sanchez, MD
|
|
x | |
6:06 PM - 6:11 PM | How And When Is It Safe To Treat Type I Endoleaks After EVAR Non-Interventionally: A 13-Year Experience |
Presenter(s):James May, MD, MS, FRACS, FACS | |
View Abstract | |
6:12 PM - 6:17 PM | How Embolization With Onyx Can Be An Effective Solution For Type I Endoleaks And Other Novel Solutions For Endoleaks After EVAR And TEVAR |
Presenter(s):Robert A. Morgan, MD | |
6:18 PM - 6:23 PM | Long-Term Follow-up Of Treated Type II Endoleaks Shows The Need For Close Surveillance And Frequent Re-Treatment |
Presenter(s):Timur P. Sarac, MD | |
6:24 PM - 6:29 PM | When Does Translumbar Glue Embolization Of Type II Endoleaks Work And When Does It Not: Tips And Tricks To Make It Effective |
Presenter(s):Neal S. Cayne, MD | |
6:30 PM - 6:35 PM | Tips And Tricks On How To Use Onyx In The Treatment Of Type I And Other Major Endoleaks |
Presenter(s):Thomas Larzon, MD | |
6:36 PM - 6:41 PM | The Anaconda Fenestrated Graft For Juxtarenal AAAs: Advantages, Limitations And 1-Year Registry Results |
Presenter(s):Nick J. Burfitt, BSc, MB, BChir, MRCS, FRCR | |
View Abstract | |
6:42 PM - 6:47 PM | Interplay Between Anatomy And Indications/Pathology In TEVAR Outcomes: Anatomic Complexity Drives Outcomes More Than Pathology/Indications |
Presenter(s):Michael C. Stoner, MD | |
View Abstract | |
6:48 PM - 6:55 PM | Panel Discussion Conclusion of Program C. |
END OF SESSION 22 | |
SESSION 23 SCHEDULE | |
Thursday
SESSION 23:
LOWER EXTREMITY ADDITIONAL TOPICS (4-MINUTE TALKS)
Moderators:Peter L. Faries, MD, FACS / Ross Milner, MD
|
|
x | |
1:00 PM - 1:04 PM | Bringing Atherectomy To The Next Level: What Is Its Future |
Presenter(s):Jos C. van den Berg, MD, PhD | |
1:05 PM - 1:09 PM | Optical Coherence Tomography Of The Femoral Arteries: How Is It Done And What Is Its Value |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
View Abstract | |
1:10 PM - 1:14 PM | Will Plaque Excision By Atherectomy Become The Treatment Of Choice For Popliteal Occlusive Disease: 1-Year Results From The DEFINITIVE LE Trial In 800 Patients |
Presenter(s):James F. McKinsey, MD | |
1:15 PM - 1:19 PM | The True Path Rotating Tip Device For Crossing Chronic Total Occlusion (CTO): How Does It Work And How Well Does It Work |
Presenter(s):John R. Laird, MD | |
1:20 PM - 1:24 PM | Relevance Of In-Stent Restenosis In Various Territories And Best Strategies For Treatment |
Presenter(s):John R. Laird, MD | |
1:25 PM - 1:29 PM | Laser Debulking And DEB For In-Stent Restenosis |
Presenter(s):Jos C. van den Berg, MD, PhD | |
1:30 PM - 1:34 PM | The Wildcat Catheter From Avinger In Crossing Difficult Aortoiliac Occlusions |
Presenter(s):Patrick E. Muck, MD, FACS | |
View Abstract | |
1:35 PM - 1:39 PM | Status Of Biodegradable Stents And Will They Work In The Periphery |
Presenter(s):Ron Waksman, MD | |
1:40 PM - 1:44 PM | Long-Term Results Of The ABSORB Trial Showing Benefits Of Biodegradable Coronary Stents: When Will We Know If They Will Work Elsewhere |
Presenter(s):Lewis B. Schwartz, MD | |
1:45 PM - 1:49 PM | Heparin Bonded Bypass Grafts, Stent-Grafts And Hybrid Grafts: Will They Make A Difference |
Presenter(s):Edward Y. Woo, MD | |
View Abstract | |
1:50 PM - 1:54 PM | Improved 3-Year Patency Of Heparin Bonded PTFE Grafts vs. PTFE Grafts Without Heparin |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
1:55 PM - 1:59 PM | Best Treatment For In-Stent Restenosis After Renal Artery Stenting |
Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
2:00 PM - 2:04 PM | Current Optimal Treatment For Long SFA Occlusions |
Presenter(s):Gary M. Ansel, MD | |
2:05 PM - 2:09 PM | Tips And Tricks For Successful Stent-Graft Treatment Of Popliteal Aneurysms |
Presenter(s):Irwin V. Mohan, MD, FRCS, FEBVS, FRACS | |
View Abstract | |
2:10 PM - 2:14 PM | Is Functional Popliteal Entrapment A Myth Or Reality |
Presenter(s):Cynthia K. Shortell, MD | |
2:15 PM - 2:19 PM | Prior Contralateral Major Amputation Predicts Worse Outcomes For Lower Extremity Revascularization In The Intact Limb |
Presenter(s):Andres Schanzer, MD | |
2:20 PM - 2:24 PM | Outcomes Of Single Segment Greater Saphenous Vein Graft Bypasses Are Better Than Those Of Alternative Autologous Vein Bypasses |
Presenter(s):Mauri J.A. Lepantalo, MD | |
View Abstract | |
2:25 PM - 2:30 PM | Panel Discussion |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Thursday
SESSION 24:
ADDITIONAL THORACIC AND ABDOMINAL AORTA TOPICS (4-MINUTE TALKS)
Moderators:Jerry Goldstone, MD, FACS, FRCSEd / Gary Giangola, MD
|
|
x | |
2:30 PM - 2:34 PM | How Much Does Stent Design Matter For The Various Thoracic Aortic Pathologies: What Are The Unmet Needs |
Presenter(s):Michael D. Dake, MD | |
2:35 PM - 2:39 PM | Initial Experience With Ascending Aortic Endografting Using The Cook Endograft For Type A Dissection |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
2:40 PM - 2:44 PM | Do Distal Bare Stents Have Value In The Treatment Of Type B Aortic Dissections |
Presenter(s):Burkhart Zipfel, MD | |
2:45 PM - 2:49 PM | The Embrella Aortic Arch Embolic Deflector: Does It Work: What Precautions Must Be Used And What Are Its Complications |
Presenter(s):Jeffrey P. Carpenter, MD | |
2:50 PM - 2:54 PM | New Classification System For Blunt Traumatic Aortic Injury To Guide In Conservative Or Endograft Treatment |
Presenter(s):Benjamin W. Starnes, MD | |
2:55 PM - 2:59 PM | Pros And Cons Of Early TEVAR With Extensive Coverage Of The Thoracic Aorta In Type B Aortic Dissections |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
3:00 PM - 3:04 PM | Diagrams Showing How To Make Sandwich Grafting Technique Work For Endovascular Treatment Of Thoracoabdominal Aneurysms |
Presenter(s):Armando C. Lobato, MD, PhD | |
3:05 PM - 3:09 PM | How Do Pressure Changes In The Excluded Aneurysm Sac Impact On Spinal Cord Ischemia After TEVAR |
Presenter(s):Bjõrn Sonesson, MD, PhD | |
View Abstract | |
3:10 PM - 3:14 PM | How Do Outcomes From A Contemporary EVAR Registry (ENGAGE Registry) Differ From Those From Older Registries Like EUROSTAR: EVAR Is Getting Better |
Presenter(s):Marc R.H. van Sambeek, MD, PhD | |
3:15 PM - 3:19 PM | Decreasing Prevalence Of AAAs And Improving Short-Term And Long-Term Outcomes After EVAR In Sweden: What Are The Reasons For Them |
Presenter(s):Anders Wanhainen, MD, PhD / Martin Bjorck, MD, PhD | |
3:20 PM - 3:24 PM | What Is The Annual Rupture Risk Of AAAs That Have Increasing Sac Size After EVAR But No Detectable Endoleak |
Presenter(s):Frans L. Moll, MD, PhD | |
3:25 PM - 3:29 PM | How Well Are The Complex (Fenestrated) Stent-Grafts Doing: UK Multicenter Study |
Presenter(s):S. Rao Vallabhaneni, MD, FRCS / Richard G. McWilliams, MD | |
View Abstract | |
3:30 PM - 3:34 PM | Optimal Current Treatment Of Infected AAAs: The Role Of Endografts |
Presenter(s):Kamphol Laohapensang, MD | |
View Abstract | |
3:35 PM - 3:39 PM | 1-Day Surgery For EVAR: Experience In >60 Patients |
Presenter(s):Zoran Rancic, MD, PhD | |
3:40 PM - 3:44 PM | How Well Do Endografts Do In The Treatment Of Aortoduodenal And Aortoesophageal Fistulas: How Can Survival Be Achieved |
Presenter(s):Bart E. Muhs, MD, PhD | |
3:45 PM - 3:49 PM | Tips And Tricks For Managing Difficult Iliac Arteries: Tug-Wire Technique To Overcome Tortuous Arteries And Balloon Slide Technique To Overcome Tiny Arteries |
Presenter(s):Thomas Larzon, MD | |
3:50 PM - 3:59 PM | Panel Discussion |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Thursday
SESSION 25:
MISCELLANEOUS IMPORTANT TOPICS (4-MINUTE TALKS)
Moderators:Michael D. Dake, MD / Krassi Ivancev, MD, PhD
|
|
x | |
THE CCSVI CONTROVERSY IN MULTIPLE SCLEROSIS | |
4:00 PM - 4:04 PM | Creation Of A New IVC In A Patient Whose IVC Was Obliterated By Trauma: An Interventional Approach |
Presenter(s):Thomas A. Sos, MD / Akhilesh Sista, MD | |
4:05 PM - 4:09 PM | What’s Happening To The Randomized Trials Comparing Interventional Treatment To Placebo Treatment Of CCSVI In MS Patients |
Presenter(s):L. Nelson Hopkins, MD | |
4:10 PM - 4:14 PM | Incidence Of Internal Jugular Vein Stenosis In Thoracic Outlet Syndrome Patients: How Does This Relate To MS And CCSVI |
Presenter(s):Sam S. Ahn, MD, MBA, FACS | |
4:15 PM - 4:19 PM | Are Venous Anomalies In MS Patients Relevant Or Not |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
4:20 PM - 4:24 PM | MS And CCSVI: Is The Relationship Real And Causally Important |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Abstract | |
4:25 PM - 4:29 PM | Improving Contemporary Usage And Techniques Result In Better Patency With Nitinol SFA Stents (Smart Stents): Based On The STROLL Trial |
Presenter(s):Marc H. Glickman, MD | |
MORE ABOUT ABDOMINAL AND THORACOABDOMINAL ANEURYSMS | |
4:30 PM - 4:34 PM | New Classification Of Suprarenal Aneurysms Based On Location Of The Proximal Seal Zone: Correlates With Mortality And Morbidity Of Fenestrated And Branched Endografts |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
4:35 PM - 4:39 PM | Is Medical Treatment To Slow Growth Of AAAs Effective: The STOPS Trial |
Presenter(s):Ronald L. Dalman, MD | |
4:40 PM - 4:44 PM | An Improved Method For Measuring AAA Size With EKG Gated 3D Ultrasound |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Abstract | |
4:45 PM - 4:49 PM | What Is The "Best" Treatment For Perigraft Hygroma With AAA Sac Enlargement After EVAR |
Presenter(s):John Blebea, MD, MBA | |
4:50 PM - 4:54 PM | Novel Method For Making Cannulation Of The Contralateral Limb Quick (<10 Seconds) And Easy During EVAR |
Presenter(s):Willem Wisselink, MD | |
4:55 PM - 5:00 PM | Panel Discussion |
MISCELLANEOUS TOPICS | |
Moderator(s): John B. Chang, MD / Elliot L. Chaikof, MD, PhD | |
5:01 PM - 5:05 PM | What Will Happen In The Effort To Separate Doctors From Industry: Predictions For The Future And What Is Happening In Massachusetts |
Presenter(s):Richard A. Baum, MD, MPA, MBA | |
5:06 PM - 5:10 PM | Principles Of Medical Treatment To Prevent Stroke |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP, FRACP | |
View Abstract | |
5:11 PM - 5:15 PM | Managing Complications Of CAS |
Presenter(s):Klaus D. Mathias, MD | |
5:16 PM - 5:20 PM | Stroke Prevention And PFO Closure: Dead Or Alive |
Presenter(s):William A. Gray, MD | |
5:21 PM - 5:25 PM | Catheter Directed Thrombolysis As Treatment For Acute SMA Occlusion |
Presenter(s):Bjõrn Sonesson, MD, PhD / Martin Bjorck, MD, PhD / Timothy A. Resch, MD, PhD | |
5:26 PM - 5:30 PM | Novel Endovascular Techniques For Treating Complex Iliac Aneurysmal Disease |
Presenter(s):Joseph L. Mills, MD / Luis R. Leon, MD, RVT, FACS | |
5:31 PM - 5:35 PM | Laparoscopic Sutureless Aortobifemoral Bypass Using The Lachat Viabahn (VORTEC) Technique |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
5:36 PM - 5:40 PM | How Do Long Bare Metal SFA Stents Perform: The DURABILITY Trial Clinical Outcomes, Treadmill Data, Objective Patency, And Routine Stent Fracture Assessment |
Presenter(s):Jon S. Matsumura, MD | |
5:41 PM - 5:45 PM | Homocysteine Is A Predictor Of Vascular Mortality: A Useful Marker Misunderstood |
Presenter(s):Afshin Assadian, MD | |
5:46 PM - 5:51 PM | Use Of Duplex Ultrasound To Facilitate Distal Tibial And Pedal Access To Treat Lower Extremity Occlusive Disease |
Presenter(s):Jihad A. Mustapha, MD | |
5:51 PM - 6:00 PM | Panel Discussion Conclusion of Program D. |
END OF SESSION 25 | |
Friday, November 16, 2012
Print Entire 2012 Program:
|
|
SESSION 26 SCHEDULE | |
Friday
SESSION 26:
NEW TECHNIQUES AND NEW ENDOVASCULAR TECHNOLOGY (5-MINUTE TALKS)
Moderators:Nicholas J. Morrissey, MD / Michael L. Marin, MD
|
|
x | |
6:40 AM - 6:45 AM | Use Of Microbubbles In The Treatment Of Acute Arterial Occlusions: How Do They Work And Do They Have Clinical Value |
Presenter(s):Willem Wisselink, MD | |
6:46 AM - 6:51 AM | How The Art-Assist Pneumatic Compression Device Can Heal Ulcers From CLI And Relieve Rest Pain Noninvasively |
Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
View Abstract | |
6:52 AM - 6:57 AM | A New Device For Topical Intermittent Compression And Hyper-Oxygenation To Improve Healing Of Infected Ischemic Foot Wounds |
Presenter(s):Magdiel Trinidad-Vazquez, MD | |
View Abstract | |
6:58 AM - 7:03 AM | US Experience With The Flow Altered Short Transcervical CAS (FAST-CAS) With Flow Reversal: The Pivotal US Trial |
Presenter(s):Christopher J. Kwolek, MD / Richard P. Cambria, MD | |
7:04 AM - 7:09 AM | Use Of Pressure Wire And CO2 Angiography To Make Renal Artery Stenting Safer And Better |
Presenter(s):Kim J. Hodgson, MD | |
7:10 AM - 7:15 AM | Predicting The Results Of Interventional Treatment Using Computational Analysis Of Blood Flow And Lesion Resistance From CT Data: Is FFR (Fractional Flow Reserve) Applicable To Peripheral Arteries As Well As Coronaries |
Presenter(s):Christopher K. Zarins, MD | |
7:16 AM - 7:21 AM | Progress In Techniques For Treating Below-Elbow Occlusions For Critical Hand Ischemia |
Presenter(s):Roberto Ferraresi, MD | |
7:22 AM - 7:27 AM | Management Of Median Arcuate Ligament: A New Treatment Paradigm Including Laparoscopic Ligament Division |
Presenter(s):Bauer E. Sumpio, MD, PhD | |
7:28 AM - 7:33 AM | Panel Discussion |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Friday
SESSION 27:
THORACOABDOMINAL AORTIC ANEURYSMS (TAAAS) AND TECHNIQUES TO REVASCULARIZE RENAL AND VISCERAL ARTERIES: CHIMNEYS, PERISCOPES AND SANDWICH GRAFTS (CHIMPS) (5-MINUTE TALKS)
Moderators:Mark A. Adelman, MD / Frank J. Veith, MD
|
|
x | |
7:33 AM - 7:38 AM | Why Parallel Grafts (CHIMPS) Work And Why A Double D Configuration Can Be Achieved With Elimination Of Gutter Endoleaks: Theoretical Considerations And How To Calculate The Right Sizes Of The Parallel Grafts |
Presenter(s):Jerry Matteo, MD | |
7:39 AM - 7:44 AM | Long-Term Results After Chimney And Periscope Grafts Up To 7 Years: Are They Durable And How To Make Them Work Well For Pararenal And TAAAs |
Presenter(s):Mario Lachat, MD / Dieter O. Mayer, MD / Zoran Rancic, MD, PhD | |
7:45 AM - 7:50 AM | Tips And Tricks For Getting Good Results With CHIMPS: When Fenestrated vs. When CHIMPS |
Presenter(s):Giovanni Torsello, MD / Konstantinos Donas, MD | |
View Abstract | |
7:51 AM - 7:56 AM | Long-Term Results After Sandwich Grafts For TAAAs: Where And When Do They Work And What Precautions Must Be Taken |
Presenter(s):Armando C. Lobato, MD, PhD | |
7:57 AM - 8:02 AM | When Do Chimneys Work And When Don’t They: Experience In >140 Patients |
Presenter(s):Thomas Larzon, MD | |
8:03 AM - 8:08 AM | How To Repair Juxtarenal AAAs Safely And Effectively With Double Chimney Grafts: Technique And Results |
Presenter(s):Jason T. Lee, MD / Ronald L. Dalman, MD | |
8:09 AM - 8:14 AM | Branched And Fenestrated Grafts Are Best: But What TAAAs Can’t Be Treated With Them And Can Sandwich Grafts Solve The Problem |
Presenter(s):Martin Malina, MD, PhD | |
8:15 AM - 8:20 AM | DEBATE: CHIMPS Are Better And Cheaper Than Branched And Fenestrated Grafts For Treating Complex Aneurysms: CHIMPS Will Always Have A Major Role |
Presenter(s):Ralf R. Kolvenbach, MD | |
View Abstract | |
8:21 AM - 8:26 AM | DEBATE: CHIMPS Are Inferior To Branched And Fenestrated Grafts For Complex Aneurysms: Long-Term Results Will Prove It: CHIMPS Will Have Only A Minor Role |
Presenter(s):Stephan Haulon, MD | |
8:27 AM - 8:32 AM | Fenestrated And Branched Grafts For EVAR - How Well Have They Performed In France When Used Widely: Based On A National Audit: How These Results Compare With Those Of The Cardiatis Multilayer Stent For Similar Lesions |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
8:33 AM - 8:38 AM | Role Of Endo, Open And Hybrid For TAAAs: When Is Open Repair Still Best |
Presenter(s):Michael J. Jacobs, MD | |
8:39 AM - 8:44 AM | Advanced Techniques For Performing EVAR With Difficult Anatomy: How To Avoid Brachial Access When Placing Chimney Or Periscope Grafts |
Presenter(s):David J. Minion, MD | |
8:45 AM - 8:50 AM | Off-The-Shelf Bifurcated EVAR Grafts For TAAAs: Does It Hold Up And How To Get A Double D Configuration With Seal Of Parallel Grafts |
Presenter(s):Karthikeshwar Kasirajan, MD | |
8:51 AM - 8:56 AM | Late Results With Physician Modified Stent Grafts For Pararenal And TAAAs: They Are As Good As Manufactured Grafts If . . . |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
8:57 AM - 9:02 AM | Branched Devices For Thoracoabdominal Aortic Aneurysms: Do The Branches Last And Suggestions For The Future |
Presenter(s):Marcelo Ferreira, MD | |
9:03 AM - 9:20 AM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Friday
SESSION 28:
NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA AND CLI (5-MINUTE TALKS)
Moderators:Peter F. Lawrence, MD / Gregg S. Landis, MD
|
|
x | |
9:20 AM - 9:25 AM | Long-Term Results With Drug Eluting Balloons (DEBs): Summary Of The Available Trials With Up To 5-Year Results Of THUNDER, DEBATE And PACIFIER Trials With Paclitaxil Coatings |
Presenter(s):Gunnar Tepe, MD | |
9:26 AM - 9:31 AM | Long-Term (2-5 Years) Results Of SFA Stent Performance In 1000 Patients (A Belgium/Germany Registry Report) |
Presenter(s):Giovanni Torsello, MD / Marc Bosiers, MD | |
View Abstract | |
9:32 AM - 9:37 AM | Promising 1-Year Patency Results For A New Prosthetic Graft (The Fusion Graft) For Above Knee Femoropopliteal Bypass: The PERFECTION Trial |
Presenter(s):Hans-Henning Eckstein, MD, PhD / Afshin Assadian, MD | |
9:38 AM - 9:43 AM | Extremity Arterial Reconstruction In Children: Tips And Precautions |
Presenter(s):James C. Stanley, MD / Jonathan Eliason, MD | |
View Abstract | |
9:44 AM - 9:49 AM | DEBATE: All CLI Patients Should Be Treated First By Endovascular Techniques |
Presenter(s):Gary M. Ansel, MD | |
9:50 AM - 9:55 AM | DEBATE: Some CLI Patients Should Be Treated By A Bypass First: Which Ones And Has Anything Changed In The Past Year |
Presenter(s):Michael S. Conte, MD | |
9:56 AM - 10:01 AM | Pros And Cons Of Bypass And PTA For Treatment Of Intermittent Claudication From SFA Occlusive Disease: Does Bypass Still Have A Role |
Presenter(s):Marc L. Schermerhorn, MD | |
10:02 AM - 10:07 AM | Endovascular Treatment Of Infrainguinal Bypass Failure And Impending Failure |
Presenter(s):Nicolas A. Diehm, MD | |
10:08 AM - 10:13 AM | 3-Year Findings Of A RCT Comparing Heparin Bonded And Standard PTFE Grafts In Infrainguinal Bypasses: Is The Benefit Of Heparin Bonding Durable |
Presenter(s):Jes S. Lindholt, MD | |
10:14 AM - 10:19 AM | Pedal Bypass To Deep Vein For CLI Can Be Effective Treatment For Extensive Ischemic Ulcer With No Suitable Outflow Artery: Tips And Tricks To Make It Work |
Presenter(s):Pramook Mutirangura, FRCS (Edinburgh) | |
View Abstract | |
10:20 AM - 10:25 AM | Nordic Pole Walking Can Improve Intermittent Claudication And Cardiac Fitness: What Is It And How Does It Work |
Presenter(s):Jonathan D. Beard, MD | |
10:26 AM - 10:31 AM | Will Stem Cell Treatment Work For CLI: The HARVEST Bone Marrow And Astrom IX MYELO CELL Trials |
Presenter(s):Richard J. Powell, MD / William A. Marston, MD | |
10:32 AM - 10:37 AM | For Claudication From Aortoiliac Occlusive Disease, Supervised Exercise Produces More Relief Than Best Medical Therapy Or Stenting: Results Of The CLEVER Trial |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
10:38 AM - 10:45 AM | Panel Discussion |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Friday
SESSION 29:
ADVANCES IN MEDICAL THERAPY OR TREATMENT OF MEDICAL PROBLEMS OR COMPLICATIONS (5-MINUTE TALKS)
Moderators:Anton N. Sidawy, MD, MPH / Plinio Rossi, MD
|
|
x | |
10:45 AM - 10:50 AM | Platelet Activity And Optimizing Antiplatelet Treatment: The Next Frontier In Vascular Disease Management |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
10:51 AM - 10:56 AM | What’s New With Endovascular Ablation Procedures For Atrial And Ventricular Arrhythmias |
Presenter(s):Larry Chinitz, MD | |
10:57 AM - 11:02 AM | Why Do Statins Decrease Preoperative And Periprocedural Risks: What Is Optimal Drug Dose And Timing |
Presenter(s):Christos D. Liapis, MD | |
View Abstract | |
11:03 AM - 11:08 AM | What’s All This Hoopla About Statins And Mental Fogginess, Increased Blood Sugar And Diabetes: Should It Make A Difference In Statin Usage Or Is It A Witch Hunt |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
11:09 AM - 11:14 AM | New Concepts Regarding The Importance Of Plaque Instability And Stability In Coronary And Vascular Disease: How Instability Should Be Determined And Treated |
Presenter(s):Gregg W. Stone, MD | |
11:15 AM - 11:20 AM | High Incidence Of Asymptomatic Elevated Troponin Levels (Troponin-Only MIs) After Open Vascular Surgery: What Does It Mean And What Can Be Done To Decrease It |
Presenter(s):Caron B. Rockman, MD | |
11:21 AM - 11:26 AM | DEBATE: Why We Should Not Stop Screening For Asymptomatic Carotid Stenosis |
Presenter(s):Glenn Jacobowitz, MD | |
11:27 AM - 11:32 AM | DEBATE: We Should Stop Screening For Asymptomatic Carotid Stenosis Even Though There Is A Substantial Incidence Of Silent Cerebral Events In These Patients: What Should We Do About It |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
11:33 AM - 11:38 AM | What’s New About The Role Of Cilostazol In Patients With Vascular Disease: What Are Some Of Its Newly Found Benefits |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
11:39 AM - 11:44 AM | DEBATE: Should Vascular Patients Be Taking A Polypill (Or Multiple Pills) For Secondary Prophylaxis: Yes, It Decreases Risk And Is Cost Effective |
Presenter(s):Don Poldermans, MD | |
View Abstract | |
11:45 AM - 11:50 AM | DEBATE: Should Vascular Patients Be Taking A Polypill (Or Multiple Pills) For Secondary Prophylaxis: No, It Is Too Dangerous; Better To Wait For Symptoms |
Presenter(s):Erich Minar, MD | |
11:51 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break (Americas Hall - 3rd Floor) Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Friday
SESSION 30:
NEW LATE BREAKING CONCEPTS, UPDATES AND MISCELLANEOUS HOT TOPICS RELATED TO LOWER EXTREMITY AND AORTIC DISEASE (5-MINUTE TALKS)
Moderators:Patrick J. Lamparello, MD / Richard M. Green, MD
|
|
x | |
LOWER EXTREMITY TOPICS | |
6:45 AM - 6:50 AM | When Are Prosthetic Grafts As Good As Vein Grafts For Leg Bypasses: An Analysis From The VSGNE |
Presenter(s):Jack L. Cronenwett, MD | |
6:51 AM - 6:56 AM | Are There Patients With CLI That We Cannot Treat Endovascularly And Tips For Treating Flush Occlusions Endovascularly |
Presenter(s):George H. Meier III, MD | |
6:57 AM - 7:02 AM | What Is The Current Role For Atherectomy: Do These Newer Devices Work Better Than Older Models: Which Device Is Best |
Presenter(s):Lawrence A. Garcia, MD | |
7:03 AM - 7:08 AM | Advantages Of Bioabsorbable Drug Eluting Stent In Iliac And Femoral Lesions: The ESPRIT Trial |
Presenter(s):Johannes Lammer, MD | |
7:09 AM - 7:14 AM | A New Composite (Goretex/Metal) Self Expanding SFA Stent: Potential Advantages And Early Results |
Presenter(s):John R. Laird, MD | |
7:15 AM - 7:20 AM | Propaten PTFE Graft: Is It As Good As Autologous Vein |
Presenter(s):Richard F. Neville, MD | |
7:21 AM - 7:26 AM | Use Of The Lachat VORTEC Sutureless Clampless Anastomotic Technique With An Endograft Connector To Simplify Femoropopliteal Bypasses |
Presenter(s):Gabriel Szendro, MD | |
View Abstract | |
7:27 AM - 7:32 AM | Creation Of A Sutureless Anastomosis With An Over-The-Wire Implantation Of A Gore Hybrid Vascular Graft For Various Bypasses And A-V Access: An Extension Of The Lachat VORTEC Technique |
Presenter(s):Edward Y. Woo, MD | |
View Abstract | |
7:33 AM - 7:38 AM | Incidence Of Internal Jugular Vein Stenosis In Thoracic Outlet Syndrome Patients: How Does This Relate To MS And CCSVI |
Presenter(s):Sam S. Ahn, MD, MBA, FACS | |
7:39 AM - 7:44 AM | Use Of OCT (Optical Coherent Tomography) For Crossing Chronic Total Occlusions |
Presenter(s):Tony S. Das, MD | |
7:45 AM - 7:53 AM | Panel Discussion |
AORTIC TOPICS | |
Moderator(s): Roger M. Greenhalgh, MD / Ali F. AbuRahma, MD | |
7:53 AM - 7:58 AM | A New One-Shot Aortic Occlusion Balloon |
Presenter(s):Benjamin W. Starnes, MD | |
7:59 AM - 8:04 AM | 3D Imaging And Robotic Catheter Navigation: How Can They Work Together To Facilitate Complex Aortic Procedures |
Presenter(s):Jean Bismuth, MD / Alan B. Lumsden, MD, FACS | |
8:05 AM - 8:10 AM | DEBATE: The Long-Term Results Of Open Repair Are Better Than Those Of EVAR In Most Patients |
Presenter(s):Wilhelm Sandmann, MD | |
8:11 AM - 8:16 AM | DEBATE: The Long-Term Results Of EVAR Are Better Than Those Of Open Repair: The EVAR I Late Results Have Been Misinterpreted In The NEJM Article |
Presenter(s):Juan C. Parodi, MD | |
8:17 AM - 8:22 AM | EVAR I Results Are Not In Accord With Contemporary Practice Results: EVAR Is Better Than Open Repair With Superior Outcomes |
Presenter(s):Ian Loftus, MD / Matt M. Thompson, MD | |
View Abstract | |
8:23 AM - 8:28 AM | DEBATE: IFUs For EVAR Should Not Be Stretched: The Results Don’t Justify It |
Presenter(s):Andres Schanzer, MD | |
8:29 AM - 8:34 AM | DEBATE: A Propensity Matched Comparison Of EVAR And Open Repair Shows That EVAR Is Superior Even When IFUs Are Stretched Because Of Imperfect Anatomy |
Presenter(s):William D. Jordan, Jr., MD | |
View Abstract | |
8:35 AM - 8:40 AM | DEBATE: Bare Stents Are The Best Treatment For Most Adult Aortic Coarctations: Why Is This So |
Presenter(s):Christoph A. Nienaber, MD, PhD | |
8:41 AM - 8:46 AM | DEBATE: Covered Stents Are The Best Treatment For Most Adult Aortic Coarctations |
Presenter(s):Dietmar H. Koschyk, MD | |
View Abstract | |
8:47 AM - 8:52 AM | Update On Use Of Atrium Advanta V12 Balloon Expandable Stent-Grafts For Treatment Of Aortic Coarctation: Advantages, Limitations And Precautions: From The OUS Trial |
Presenter(s):Elchanan Bruckheimer, MBBS | |
8:53 AM - 8:58 AM | Are Fenestrated And Branched Endografts A Better Option For Treating Chronic Type B Aortic Dissections And Associated Aneurysms |
Presenter(s):Stephan Haulon, MD | |
8:59 AM - 9:08 AM | Panel Discussion |
9:09 AM - 9:25 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Friday
SESSION 31:
PROGRESS IN THE TREATMENT OF VENOUS DISEASE – PART IA (5-MINUTE TALKS)
Moderators:Mark H. Meissner, MD / Lowell S. Kabnick, MD, FACS, FACPh
|
|
x | |
9:25 AM - 9:30 AM | Current Treatment For Giant A-V Fistulas Of Renal And Visceral Vessels: Is Endovascular Treatment Feasible And How |
Presenter(s):Peter Gloviczki, MD | |
9:31 AM - 9:36 AM | Current Optimal Surgical Treatment Of Phlegmasia Cerulea Dolens |
Presenter(s):Kamphol Laohapensang, MD | |
View Abstract | |
9:37 AM - 9:42 AM | Incidence Of Upper Extremity DVT After Central Venous Catheter Placement: Implications And What To Do About It |
Presenter(s):Gregory L. Moneta, MD | |
9:43 AM - 9:48 AM | Superior Vena Cava Aneurysm: Natural History And Indications For Treatment |
Presenter(s):J. Leonel Villavicencio, MD | |
9:49 AM - 9:54 AM | Venous Aneurysms: What Are They And Are They Dangerous: Rupture Risk Has Been Exaggerated And Not All Need To Be Repaired |
Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd | |
View Abstract | |
9:55 AM - 10:00 AM | Tips And Tricks For Iliac Vein And IVC Stenting: Access, Crossing Lesions, Stent Choice And Size |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
10:01 AM - 10:06 AM | Current Status Of Stenting For Iliac Vein And Caval Disease: Indications, Which Stent Is Best, Precautions |
Presenter(s):Seshadri Raju, MD / Peter Neglen, MD, PhD | |
View Abstract | |
10:07 AM - 10:12 AM | Iliac Vein Stenting For Advanced Chronic Venous Disease: When Will It Improve Symptoms And When Will It Not: Is IVUS Essential |
Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD | |
View Abstract | |
10:13 AM - 10:18 AM | Connecticut Experience With Wall Stenting For Iliac Vein Disease Under IVUS Control: Raju And Neglen Are Right |
Presenter(s):Paul J. Gagne, MD | |
View Abstract | |
10:19 AM - 10:24 AM | Is There Any Treatment Available For Patients Who Already Have Postthrombotic Syndrome? |
Presenter(s):Jose I. Almeida, MD, FACS, RVT | |
10:25 AM - 10:35 AM | Panel Discussion |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Friday
SESSION 32:
PROGRESS IN THE TREATMENT OF VENOUS DISEASE – PART 1B (5-MINUTE TALKS)
Moderators:Bo G. Eklof, MD, PhD / Jose I. Almeida, MD, FACS, RVT
|
|
x | |
10:35 AM - 10:40 AM | Current Optimal Management Of Paget-Schroetter Syndrome |
Presenter(s):George H. Meier III, MD | |
10:41 AM - 10:46 AM | Upper Extremity DVT: Early Lysis And Rib Resection Improves Outcomes |
Presenter(s):Ian Loftus, MD | |
10:47 AM - 10:52 AM | 1-Stage Aggressive Treatment Of Paget-Schroetter Syndrome: What Does It Involve And Why Is It Best |
Presenter(s):Karl A. Illig, MD | |
10:53 AM - 10:58 AM | Robotic First Rib Resection For Paget-Schroetter Syndrome: Why Is It Better |
Presenter(s):Richard F. Neville, MD | |
10:59 AM - 11:04 AM | Current Results Of Thrombolysis Followed By Immediate Thoracic Outlet Decompression For Paget-Schroetter Syndrome |
Presenter(s):Enrique Criado, MD, FACS | |
11:05 AM - 11:10 AM | How To Treat Central Vein Stenoses: A Lesion Specific Approach |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
11:11 AM - 11:16 AM | DEBATE: The Postthrombotic Syndrome Is Underestimated In Iliofemoral DVT: It Is Decreased By Endovascular Treatment And Benefit Correlates With Elimination Of Clot |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
11:17 AM - 11:22 AM | DEBATE: The Postthrombotic Syndrome Is Not So Bad: Endovascular Treatment Is Rarely Indicated |
Presenter(s):Gregory L. Moneta, MD | |
11:23 AM - 11:28 AM | Current Status Of The Optimal Treatment For Managing Calf Vein DVT Based On The Latest Meta-analysis And Systematic Review |
Presenter(s):Elna M. Masuda, MD | |
View Abstract | |
11:29 AM - 11:34 AM | Long-Term Results After Lysis For DVT |
Presenter(s):Rabih A. Chaer, MD / Michel S. Makaroun, MD | |
11:35 AM - 11:40 AM | The New Antithrombotic Drugs: When Should They Be Used And When Shouldn’t They |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
11:41 AM - 11:46 AM | Treatment Of Central Venous Lesions With Covered Stents: Indications, Techniques And Results |
Presenter(s):Jean Bismuth, MD | |
11:47 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Americas Hall 1 (3rd Floor)Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Friday
SESSION 33:
MORE ON TEVAR, TAAAS AND PARARENAL ANEURYSMS, THEIR TREATMENT AND THE MULTILAYER STENT (5-MINUTE TALKS)
Moderators:Ronald M. Fairman, MD / Mark A. Adelman, MD
|
|
x | |
1:00 PM - 1:05 PM | Fenestrated And Branched Grafts To Repair Visceral Patch Aneurysms After Open TAAA Repair |
Presenter(s):James H. Black III, MD | |
1:06 PM - 1:11 PM | Risk Stratification And Prediction Of Long-Term Success After TEVAR For Thoracic Aneurysm Based On The MOTHER Registry |
Presenter(s):Ian Loftus, MD / Matt M. Thompson, MD | |
View Abstract | |
TOPICS RELATED TO THE MULTILAYER FLOW MODULATING STENT | |
1:12 PM - 1:17 PM | Value Of The Cardiatis Multilayer Flow Modulating Stent For The Treatment Of Non-Aortic Aneurysms |
Presenter(s):Maria Antonella Ruffino, MD / Claudio Rabbia, MD, PhD | |
View Abstract | |
1:18 PM - 1:23 PM | Does The Multilayer Stent Exclude And Fix Aortic Aneurysms: Summary Of The French Experience |
Presenter(s):Claude D. Vaislic, MD | |
1:24 PM - 1:29 PM | Results Of Treatment Of Complex TAAAs With The Multilayer Uncovered Stent: The Moroccan Experience |
Presenter(s):Amira Benjelloun, MD | |
1:30 PM - 1:35 PM | With TAAAs, Does The Multilayer Stent Promote Aneurysm Sac Shrinkage And Prevent Rupture: What Is The Evidence |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC / Niamh Hynes, MD | |
1:36 PM - 1:41 PM | Chinese Experience With The Multilayer Stent For Treatment Of Complex Aortic Aneurysms |
Presenter(s):Qingsheng Lu, MD / Zaiping Jing, MD | |
1:42 PM - 1:47 PM | Is The Multilayer Stent An Effective Treatment For Arch Aneurysms And TAAAs: What Happens To Sac Pressure And Aneurysm Size After Treatment: Is Rupture Prevented |
Presenter(s):Thomas Larzon, MD | |
1:48 PM - 1:53 PM | DEBATE: The Multilayer Stent Is Going To Work For The Treatment Of Complex Aortic Aneurysms: Theoretical Considerations And Clinical Experience |
Presenter(s):Edward B. Diethrich, MD | |
1:54 PM - 1:59 PM | DEBATE: The Multilayer Stent Is Not Going To Work For The Treatment Of Complex Aneurysms: Theoretical Considerations |
Presenter(s):Luigi Inglese, MD | |
2:00 PM - 2:05 PM | Another Skeptical View On The Value Of The Multilayer Stent For The Treatment Of Complex Aortic Aneurysms |
Presenter(s):Piergiorgio Cao, MD, FRCS | |
2:06 PM - 2:12 PM | Panel Discussion |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Friday
SESSION 34:
PROGRESS IN VASCULAR IMAGING AND GUIDANCE (5-MINUTE TALKS)
Moderators:Brian R. Hopkinson, ChM, FRCS / John H. Furtek, BS, RT(r)
|
|
x | |
2:12 PM - 2:17 PM | Can Noninvasive Imaging Keep Up With Evolving Technology |
Presenter(s):Allan W. Reid, FRCR | |
2:18 PM - 2:23 PM | All The Things You Can Learn From Transcranial Doppler (TCD) That Most Of Us Don’t Know About: A New Look At TCD |
Presenter(s):Zsolt Garami, MD | |
2:24 PM - 2:29 PM | The Value Of Hansen Magellen Robotic Assisted Catheter Manipulation For Complex Aortic Endografting |
Presenter(s):Nicholas J.W. Cheshire, MD | |
2:30 PM - 2:35 PM | Little Known Tips And Tricks For Making CO2 Angiography Work Better Than Commonly Thought |
Presenter(s):Kyung Cho, MD | |
View Abstract | |
2:36 PM - 2:41 PM | What Is The Best Prophylaxis For Contrast Induced Nephropathy (CIN) In Patients Undergoing Angiography: Does Saline Beat Bicarbonate And Mucomist: What Is The Best Regimen |
Presenter(s):Barry T. Katzen, MD | |
2:42 PM - 2:47 PM | IVUS Guided EVAR And TEVAR Is Feasible And Effective: Tips And Tricks |
Presenter(s):Martin R. Back, MD | |
View Abstract | |
2:48 PM - 2:53 PM | Vascular Imaging Strategies For Patients With Renal Insufficiency Requiring MR Imaging |
Presenter(s):Barry Stein, MD, FSIR, FACR | |
2:54 PM - 2:59 PM | Noninvasive Quantification Of Pressure Gradients And Flow With 4D Flow Sensitive MRI: What Unique Information Can This Technique Tell Us In Aortic Dissection |
Presenter(s):Jon S. Matsumura, MD / Chris Francois, MD | |
3:00 PM - 3:05 PM | Encouraging 1-Year Clinical Results With A spiral Flow Prosthetic Graft In Lower Extremity Bypasses |
Presenter(s):Nick Shaper, FRCS | |
View Abstract | |
3:06 PM - 3:30 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Friday
SESSION 35:
MORE NEW CONCEPTS ABOUT AAAS, EVAR AND OTHER TREATMENTS OF AORTIC DISEASE (5-MINUTE TALKS)
Moderators:Timur P. Sarac, MD / Palma M. Shaw, MD
|
|
x | |
1:00 PM - 1:05 PM | Fenestrated Cuff-Extender For Treatment Of Migrated Infrarenal Endografts: Midterm Results |
Presenter(s):Krassi Ivancev, MD, PhD | |
View Abstract | |
1:06 PM - 1:11 PM | Do Most AAA Patients Survive Long Enough To Benefit From Aneurysm Repair |
Presenter(s):Jack L. Cronenwett, MD | |
1:12 PM - 1:17 PM | New Findings Regarding Treatment Of Infection Following AAA Repair By EVAR Or Open Surgery |
Presenter(s):Laura Capoccia, MD, PhD | |
1:18 PM - 1:23 PM | Strategies To Minimize Blood Loss During EVAR Procedures And Why It Is Important |
Presenter(s):Claude Mialhe, MD | |
View Abstract | |
1:24 PM - 1:29 PM | Off-The-Shelf Device For Pararenal Aneurysms |
Presenter(s):Mark A. Farber, MD | |
1:30 PM - 1:35 PM | How To Place Bifurcated Devices In Patients With Iliac Occlusions |
Presenter(s):David J. Minion, MD / Mark A. Farber, MD / William D. Jordan, Jr., MD | |
1:36 PM - 1:41 PM | When Should Thoracic Endografts Be Ballooned: How Can Ballooning Be Harmful |
Presenter(s):Jean Bismuth, MD | |
1:42 PM - 1:47 PM | Endovascular Treatment Of Various Pathologic Lesions Involving The Aortic Arch |
Presenter(s):Dittmar Boeckler, MD | |
1:48 PM - 1:53 PM | Endovascular Treatment Of Aortic Arch Lesions: What Device Can Be Used To Treat Which Lesions |
Presenter(s):Sonia Ronchey, MD / Nicola Mangialardi, MD | |
1:54 PM - 1:59 PM | Use Of Motor Evoked Potential And Leaving A Side Branch Open With Delayed Closure To Prevent Spinal Cord Ischemia During Endovascular TAAA Repair |
Presenter(s):Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD | |
2:00 PM - 2:05 PM | Experience With Endostapling (Aptus HeliFX) For Endograft Fixation: It Really Works With Short Necks In The Abdominal And Thoracic Aorta |
Presenter(s):Burkhart Zipfel, MD | |
2:06 PM - 2:12 PM | Panel Discussion And Break |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Friday
SESSION 36:
MORE NEW CONCEPTS AND DATA RELATED TO THORACOABDOMINAL AND PARARENAL ANEURYSMS AND CHIMPS (5-MINUTE TALKS)
Moderators:Roy K. Greenberg, MD / Keith D. Calligaro, MD
|
|
x | |
2:12 PM - 2:17 PM | Intrasac Flow Characteristics Of An Enlarging AAA With A Type II Endoleak After EVAR: What To Do To Fix It |
Presenter(s):Julio A. Rodriguez-Lopez, MD | |
2:18 PM - 2:23 PM | How To Eliminate Gutter Leakage After Chimney And Periscope Grafts: Based On An In Vitro Measurement Study |
Presenter(s):Jan D. Blankensteijn, MD | |
2:24 PM - 2:29 PM | Endograft Type And Sizing For Successful Parallel Endografts Or CHIMPS |
Presenter(s):David J. Minion, MD | |
2:30 PM - 2:35 PM | I Have Been Converted: For Some TAAAs Open Surgery Should Be Replaced By Endovascular Treatments: When Should It Not Be |
Presenter(s):Joseph S. Coselli, MD | |
View Abstract | |
2:36 PM - 2:41 PM | Is There A Difference In Outcome Between Double And Triple Or Quadruple Fenestrated Grafts: Findings Of The GLOBALSTAR Registry |
Presenter(s):Peter L. Harris, MD, FRCS / S. Rao Vallabhaneni, MD, FRCS | |
View Abstract | |
2:42 PM - 2:47 PM | CHIMPS: How And When Do They Work And When Don’t They |
Presenter(s):Ralf R. Kolvenbach, MD | |
2:48 PM - 2:53 PM | DEBATE: CHIMPS Will Have A Major Role Even When Fenestrated And Branched Grafts Are Widely Available |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
2:54 PM - 2:59 PM | DEBATE: The Current State-Of-The-Art In Fenestrated And Branched Endografts: When Widely Available They Will And Should Eliminate The Need For CHIMPS |
Presenter(s):Roy K. Greenberg, MD / Tara M. Mastracci, MD | |
3:00 PM - 3:05 PM | What Can Be Expected From Chimney Grafts In Para And Juxtarenal AAAs: Are They As Good As Some Say |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
3:06 PM - 3:11 PM | Tips And Tricks To Make Chimney Grafts Work For Juxta And Pararenal AAAs |
Presenter(s):Alan M. Graham, MD | |
3:12 PM - 3:17 PM | A Simple Technique Of Limb Perfusion To Prevent Limb Ischemia From Complex Lengthy EVARs |
Presenter(s):Timothy A. Resch, MD, PhD | |
3:18 PM - 3:30 PM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Friday
SESSION 37:
UPDATES, CONTROVERSIES AND NEW CONCEPTS IN THE TREATMENT OF RUPTURED AAAS (5-MINUTES TALKS)
Moderators:Nicholas J.W. Cheshire, MD / Frank J. Veith, MD
|
|
x | |
3:30 PM - 3:35 PM | Update On Dutch Ruptured AAA RCT Of EVAR vs. Open Repair |
Presenter(s):Willem Wisselink, MD | |
3:36 PM - 3:41 PM | DEBATE: We Still Need Level I Evidence To Support Use Of EVAR With Ruptured AAAs: Update On The Findings Of The UK IMPROVE Trial |
Presenter(s):Janet T. Powell, MD, PhD | |
3:42 PM - 3:47 PM | DEBATE: We Don’t Need A RCT: All Ruptured AAAs Can Be Treated Endovascularly And The Results Are Excellent |
Presenter(s):Dieter O. Mayer, MD / Thomas Larzon, MD | |
3:48 PM - 3:53 PM | EVAR Must Be Part Of Any Ruptured AAA Program: Based On A Consensus Panel Finding |
Presenter(s):Marc R.H. van Sambeek, MD, PhD | |
View Abstract | |
3:54 PM - 3:59 PM | Why Open Repair Is Still The Gold Standard For Treatment Of Ruptured AAA |
Presenter(s):Jürg Schmidli, MD | |
4:00 PM - 4:05 PM | DEBATE: With Ruptured AAAs The Turn-Down Rate For Treatment Is Key |
Presenter(s):Ian Loftus, MD / Matt M. Thompson, MD | |
View Abstract | |
4:06 PM - 4:11 PM | DEBATE: Technique Not Turn-Down Rate Is Important: Tips And Tricks To Get Good Outcomes From EVAR For AAAs Short-Term And Long-Term |
Presenter(s):Mario Lachat, MD / Dieter O. Mayer, MD / Frank J. Veith, MD | |
4:12 PM - 4:17 PM | Are Outcomes Of Treatment For Ruptured AAAs Better If A Specialist Vascular Surgeon Is Caring For The Patient Than Some Other Specialist (General Surgeon Or Cardiac Surgeon) |
Presenter(s):Florian Dick, MD | |
4:18 PM - 4:23 PM | Prophylactic Use Of Polypropylene Mesh Overlay In Open Repair For AAAs Decreases The 30% Incisional Hernia Rate |
Presenter(s):Sebastian E. Debus, MD, PhD | |
4:24 PM - 4:29 PM | Is The Transfer Of RAAA Patients To Specialized Centers From Smaller Hospitals Worthwhile: A UK Delphi Consensus Study Shows It Is Under Certain Conditions |
Presenter(s):Robert J. Hinchliffe, MD | |
4:30 PM - 4:35 PM | Estimating AAA Rupture Risk: It Is Not Just Diameter: Quantitation Of Other Easily Determinable Factors |
Presenter(s):Jesper Swedenborg, MD, PhD | |
View Abstract | |
4:36 PM - 4:41 PM | Degree Of Calcification As A Prognostic Factor For Rupture With AAAs |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
View Abstract | |
4:42 PM - 4:52 PM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Friday
SESSION 38:
NEW LATE BREAKING CONCEPTS AND RESULTS IN AORTIC TRAUMATIC TRANSECTION AND TYPE B AORTIC DISSECTIONS (5-MINUTE TALKS)
Moderators:Edward B. Diethrich, MD / Keith D. Calligaro, MD
|
|
x | |
4:53 PM - 4:58 PM | Endovascular Treatment Of Traumatic Aortic Transection In Young Patients: Problems Encountered And How To Solve Them |
Presenter(s):Giorgio M. Biasi, MD | |
4:59 PM - 5:04 PM | Impact Of Proper Device Sizing In Traumatic Aortic Injuries: How Should Graft Size Be Determined |
Presenter(s):Mark A. Farber, MD | |
5:05 PM - 5:10 PM | 10-Year Follow-up Of TEVAR For Traumatic Aortic Transection: How Durable Is The Procedure And The Endograft |
Presenter(s):Karl H. Orend, MD | |
5:11 PM - 5:16 PM | What Happens After TEVAR For Traumatic Aortic Transection |
Presenter(s):Mark Conrad, MD / Richard P. Cambria, MD | |
5:17 PM - 5:22 PM | A New More Accurate Method For Measuring False Lumen Thrombosis (FLTx) In Type B Aortic Dissections: 3D MRI With Blood Pool Contrast Agent Obviates Overestimation Of FLTx |
Presenter(s):Peter R. Taylor, MA, MChir, FRCS, ARCM / Rachel Clough, MD, PhD | |
View Abstract | |
5:23 PM - 5:28 PM | Computational Flow Analysis In Type B Aortic Dissections: Lessons Learned |
Presenter(s):Zhuo Cheng, PhD | |
5:29 PM - 5:34 PM | Volumetric Assessment Of Type B Aortic Dissections On CT Imaging: Can We Predict Which Patients Will Have False Lumen Thrombosis |
Presenter(s):Frank R. Arko, MD | |
5:35 PM - 5:40 PM | DEBATE: Fenestrated And Branched Endograft Solutions Are Better Than A Petticoat Graft (Proximal Covered Stent And Distal Bare Stent) For Complicated Type B Aortic Dissections |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
5:41 PM - 5:46 PM | DEBATE: Fenestrated And Branched Endografts Are Not Better Than A Petticoat Graft For Complicated Type B Dissections – Even If Chronic |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
5:47 PM - 5:52 PM | Update From The STABLE Trial: The Petticoat Concept Of A Proximal Covered Stent And A Distal Bare Stent Is Supported By Follow-up To 2 Years: When Is The Distal Bare Stent Indicated |
Presenter(s):Joseph V. Lombardi, MD | |
5:52 PM - 6:00 PM | Panel Discussion |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Friday
SESSION 39:
MORE PROGRESS IN THE TREATMENT OF VENOUS DISEASE - PART IIA (5-MINUTE TALKS)
Moderators:Joann Lohr, MD / J. Leonel Villavicencio, MD
|
|
x | |
3:30 PM - 3:35 PM | Neurological Complications Of Sclerotherapy For Varicose Veins: Incidence And Prevention |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
3:36 PM - 3:41 PM | Radiofrequency Treatment Of Perforating Veins For Recalcitrant Venous Ulcers: How To Do It And Does It Help |
Presenter(s):Peter F. Lawrence, MD | |
3:42 PM - 3:47 PM | Local Hyperbaric O2 To Heal Refractory Venous Ulcers |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC / Niamh Hynes, MD | |
3:48 PM - 3:53 PM | Update And Clinical Experience With Biodegradable IVC Filter |
Presenter(s):David Rosenthal, MD | |
View Abstract | |
3:54 PM - 3:59 PM | Why Routine IVC Filters Should Be Placed In Patients With Massive And Submassive PEs |
Presenter(s):Gary M. Ansel, MD | |
4:00 PM - 4:05 PM | Novel Technique For Removing Retrievable IVC Filter When Its Hook Cannot Be Snared |
Presenter(s):Benjamin M. Jackson, MD / Ronald M. Fairman, MD | |
View Abstract | |
4:06 PM - 4:11 PM | Non-Lipid Lowering Effects Of Crestor On DVT |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
4:12 PM - 4:17 PM | Improved Bioprosthetic Valve For Treatment Of Deep Venous Insufficiency: Value Of Autologous Endothelial Cells |
Presenter(s):Dusan Pavcnik, MD, PhD | |
4:18 PM - 4:23 PM | Superficial Vein Thrombophlebitis: To Treat Or Not To Treat |
Presenter(s):Joseph D. Raffetto, MD | |
4:24 PM - 4:29 PM | How To Decrease The Risk Of Anastomotic Stenosis And Occlusion In Bypasses For Takayasu’s Disease |
Presenter(s):Byung-Boong Lee, MD | |
View Abstract | |
4:30 PM - 4:40 PM | Panel Discussion |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Friday
SESSION 40:
PROGRESS IN ENDOVASCULAR TREATMENT OF MASSIVE AND SUBMASSIVE PULMONARY EMBOLI AND OTHER HOT VENOUS TOPICS – PART IIB (5-MINUTE TALKS)
Moderators:Bo G. Eklof, MD, PhD / Nicholas J. Morrissey, MD
|
|
x | |
4:40 PM - 4:45 PM | Ultrasound-Assisted Thrombolysis For Massive And Submassive PE |
Presenter(s):Nils Kucher, MD / Iris Baumgartner, MD | |
4:46 PM - 4:51 PM | New Findings In The Use Of Ultrasound Accelerated Thrombolysis In The Treatment Of Submassive PEs |
Presenter(s):Tod C. Engelhardt, MD | |
View Abstract | |
4:52 PM - 4:57 PM | Endovascular Treatment Of Massive PE: How And When Should It Be Done |
Presenter(s):David L. Gillespie, MD | |
4:58 PM - 5:03 PM | Update On VORTEX Suction Thrombectomy Catheter To Treat PEs And IVC Thrombi: Clinical Experience, Safety And Precautions |
Presenter(s):Christopher J. Kwolek, MD | |
5:04 PM - 5:09 PM | Does Treatment With The Trellis Mechanical Thrombectomy Device Decrease The Postthrombotic Syndrome After 2 Years: Results Of The ISOL-8 Multicenter Trial |
Presenter(s):Paul J. Gagne, MD | |
View Abstract | |
5:10 PM - 5:15 PM | Value Of Ultrasound Accelerated Thrombolysis In DVT: When Is It Indicated |
Presenter(s):Cees H.A. Wittens, MD, PhD | |
5:16 PM - 5:21 PM | Update On New Anticoagulants For Venous Thromboembolism Prophylaxis And Treatment |
Presenter(s):Thomas W. Wakefield, MD | |
View Abstract | |
5:22 PM - 5:27 PM | Should Venous IVUS Be Used In All Serious Leg Swelling Patients To Detect Lymphedema From Venous Disease So It Can Be Treated By Stenting |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
5:28 PM - 5:33 PM | New Technique For Deep Venous Valve Reconstruction |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
5:34 PM - 5:39 PM | The Relationship Between Venous And Arterial Disease: Is Venous Disease Really An Arterial Problem |
Presenter(s):Seshadri Raju, MD | |
View Abstract | |
5:40 PM - 5:45 PM | How Should We Manage The Unretrievable Retrievable IVC Filter |
Presenter(s):Werner Lang, MD | |
5:46 PM - 6:00 PM | Panel Discussion |
END OF SESSION 40 | |
Saturday, November 17, 2012
Print Entire 2012 Program:
|
|
SESSION 41 SCHEDULE | |
Saturday
SESSION 41:
NEW DEVELOPMENTS IN AAAS AND THEIR TREATMENT (5-MINUTE TALKS)
Moderators:K. Wayne Johnston, MD, FRCS / Dhiraj M. Shah, MD
|
|
x | |
6:40 AM - 6:45 AM | Impact Of A Redeployable AAA Stent-Graft (Gore Excluder C-3) To Improve Proximal Seal In Difficult Anatomy: Does It Make A Difference |
Presenter(s):Eric L.G. Verhoeven, MD, PhD | |
View Abstract | |
6:46 AM - 6:51 AM | Is A Thick Layer Of Neck Thrombus A Contraindication For EVAR |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
6:52 AM - 6:57 AM | Final Result Of The PEVAR Trial: A RCT Comparing Percutaneous With Open Access For EVAR |
Presenter(s):Zvonimir Krajcer, MD, FACC | |
6:58 AM - 7:03 AM | Open And Endovascular Repair Of Para-Anastomotic Aneurysms |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
7:04 AM - 7:09 AM | Transecting The Left Renal Vein For Aortic Surgery: Why, How, When, Where And Why Not |
Presenter(s):Afshin Assadian, MD | |
7:10 AM - 7:15 AM | DEBATE: Laparoscopic Vascular Surgery Should Be Growing And Vascular Surgeons Should Learn It And Do It |
Presenter(s):Joseph S. Giglia, MD | |
7:16 AM - 7:21 AM | DEBATE: Why Laparoscopic And Robotic Aortic Surgery Are Losing Their Appeal And Will Not Become Widespread |
Presenter(s):Willem Wisselink, MD | |
7:22 AM - 7:27 AM | The Rise And Fall Of AAAs: The Decreasing Incidence Of AAAs: What Is The Cause |
Presenter(s):Frank A. Lederle, MD | |
7:28 AM - 7:33 AM | Is EVAR Indicated And Justified For Inflammatory AAAs: When Is It Not |
Presenter(s):Samuel R. Money, MD, MBA | |
7:34 AM - 7:39 AM | Is There A Role For AUI Endografts For EVAR In 2012: Should One Be In Your Endovascular Tool Box For Emergency Use |
Presenter(s):Thomas L. Forbes, MD | |
View Abstract | |
7:40 AM - 7:45 AM | Feasibility Of EVAR For Infected AAAs: When Does It Work And When Doesn’t It |
Presenter(s):Chung-Dann Kan, PhD | |
7:46 AM - 7:51 AM | How To Manage Infected Aortic Endografts |
Presenter(s):Edward Y. Woo, MD / Ronald M. Fairman, MD | |
View Abstract | |
7:52 AM - 7:57 AM | Long-Term Quality Of Life Data After EVAR And Open Repair: From The DREAM Trial: Open Repair Wins And Why |
Presenter(s):Jan D. Blankensteijn, MD | |
7:58 AM - 8:03 AM | The Vital Focus On EVAR vs. Open Repair At 15 Years: Is The Game Changing |
Presenter(s):Roger M. Greenhalgh, MD | |
8:04 AM - 8:12 AM | Panel Discussion |
END OF SESSION 41 | |
SESSION 42 SCHEDULE | |
Saturday
SESSION 42:
NEW DEVELOPMENTS IN TREATMENT OF THE AORTA AND ITS BRANCHES (5-MINUTE TALKS)
Moderators:Ross Milner, MD / Jean-Pierre Becquemin, MD, FRCS
|
|
x | |
8:13 AM - 8:18 AM | How Does Transcatheter Intra-arterial Denervation Work: Who Should Be Treated And Who Should Not: Why Is The Artery Not Injured And Are There Dangers From The Treatment |
Presenter(s):Yvonne Bausback, MD / Dierk Scheinert, MD | |
8:19 AM - 8:24 AM | What Are The Secondary Benefits – Other Than Reducing Blood Pressure – To Renal Denervation: When Will This Treatment Be Available In The US And How Long Will All Benefits Last |
Presenter(s):Michael R. Jaff, DO / Ido Weinberg, MD, MSc | |
8:25 AM - 8:30 AM | Status Of Renal PTA And Stenting After ASTRAL And CORAL: What’s New In The Field |
Presenter(s):Thomas A. Sos, MD | |
8:31 AM - 8:36 AM | Frontiers In Renal Artery Stenting: What Does The Future Hold: Better Stents, Better Balloons, Etc. |
Presenter(s):Max Amor, MD | |
8:37 AM - 8:42 AM | Long-Term Outcomes Of PTA And/Or Stenting For Renal Fibromuscular Hyperplasia: What Is The Best Treatment |
Presenter(s):Albeir Y. Mousa, MD / Ali F. AbuRahma, MD | |
8:43 AM - 8:48 AM | Best Method To Assess SMA Stents: How Does Duplex Correlate With Pressure Measurements, CTA And Clinical Outcomes |
Presenter(s):Timothy A. Resch, MD, PhD | |
8:49 AM - 8:54 AM | Early And Late Outcomes Of PTA And Stenting Of Celiac And SMA Occlusive Disease: Advantages, Limitations And Results Up To 10 Years |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
8:55 AM - 9:00 AM | Can The Results Of Mesenteric Revascularization Improve With Covered Stents And Distal Protection Devices |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
9:01 AM - 9:06 AM | How To Treat Isolated SMA Dissections: When Medical vs. Interventional vs. Surgical Therapy |
Presenter(s):Young Wook Kim, MD | |
View Abstract | |
9:07 AM - 9:13 AM | Panel Discussion |
Moderator(s): Enrico Ascher, MD / James C. Stanley, MD | |
9:14 AM - 9:19 AM | DEBATE: Treatment Of Mid-Aortic Syndrome In Young Adults: Interventional Treatment Is Indicated In Some |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
View Abstract | |
9:20 AM - 9:25 AM | DEBATE: Interventional Therapy Is Never Indicated For Mid-Aortic Syndrome At Any Age: Open Surgery Is Best |
Presenter(s):Wilhelm Sandmann, MD | |
9:26 AM - 9:31 AM | When Are Reentry Devices And Covered Stents Needed For Iliac Occlusive Lesions |
Presenter(s):Jörn O. Balzer, MD, PhD | |
9:32 AM - 9:37 AM | DEBATE: Open Surgery Is Still Needed For Some Aortoiliac Occlusive Lesions: Which Ones |
Presenter(s):Michel S. Makaroun, MD | |
9:38 AM - 9:43 AM | DEBATE: Endovascular Treatment Is Best For All Aortoiliac Occlusive Lesions |
Presenter(s):Martin Malina, MD, PhD | |
9:44 AM - 9:49 AM | Endovascular Treatment Of Juxtarenal Aortic Occlusions Should Always Be Possible Using Chimneys And Other Adjuncts |
Presenter(s):Sonia Ronchey, MD / Nicola Mangialardi, MD | |
9:50 AM - 9:55 AM | Use Of Advanta V12 Covered Stents For Endovascular Reconstruction Of The Aortoiliac Bifurcation To Treat Complex Occlusive Lesions |
Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
View Abstract | |
9:56 AM - 10:20 AM | Panel Discussion And Break Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Saturday
SESSION 43:
FUTURE ISSUES REGARDING HEALTH CARE; CONFLICT OF INTEREST; GOVERNMENT; INDUSTRY RELATIONS; BUSINESS OF MEDICINE; PRACTICE COSTS; AND REIMBURSEMENTS (5-MINUTE TALKS)
|
|
x | |
10:20 AM - 10:25 AM | How To Succeed With A Physician Founded Medical Device Company: The Embrella Device As An Example |
Presenter(s):Jeffrey P. Carpenter, MD | |
10:26 AM - 10:31 AM | Physician Focused Tort Reform By Limiting Expert MD Testimony Fees And Taking Other Accountability Measures: We Physicians Can Stop Medical Malpractice Abuses No Matter What The Damned Lawyers Do |
Presenter(s):O. William Brown, MD, JD | |
View Abstract | |
10:32 AM - 10:37 AM | What Will Health Care Reform Mean To Practicing Vascular Surgeons, Hospitals And Surgical Services |
Presenter(s):Robert M. Zwolak, MD, PhD | |
10:38 AM - 10:43 AM | What’s Happening With Vascular Reimbursement |
Presenter(s):Sean P. Roddy, MD | |
10:44 AM - 10:49 AM | What Is A Vascular Surgeon Worth To A Health Care System: A Look At The Finances Surrounding Vascular Care |
Presenter(s):Michael C. Stoner, MD | |
View Abstract | |
10:50 AM - 10:55 AM | Disclosure And Conflict Of Interest: Have We Gone Too Far Or Not Far Enough |
Presenter(s):Timothy M. Sullivan, MD | |
10:56 AM - 11:01 AM | Current Status Of The Physician-Industry Relationship: Update On What The Government, Our Medical Schools And Our Hospitals Are Doing To Separate Doctors From Industry |
Presenter(s):Barry T. Katzen, MD | |
11:02 AM - 11:07 AM | Physician-Industry Relationships And Conflict Of Interest: No Conflict – No Interest – No Success: How To Deal With The Pitfalls And Problems – Legally And Ethically |
Presenter(s):Scott L. Stevens, MD | |
11:08 AM - 11:13 AM | What Is Happening With The Physician-Industry Relationship In Community Practice |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
11:14 AM - 11:19 AM | Cost Analysis Of Carotid Interventions In Asymptomatic Patients |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
11:20 AM - 11:25 AM | Do Outcomes Of CEA Differ Among Different Specialties – Vascular Surgeons, General Surgeons And Neurosurgeons: Who Does The Best |
Presenter(s):Carlos H. Timaran, MD / Ali F. AbuRahma, MD | |
11:26 AM - 11:31 AM | What Has And Will The FDA Do To Medical Innovation In The US: An Innovator’s Perspective: Will Things Improve |
Presenter(s):Edward B. Diethrich, MD | |
11:32 AM - 11:37 AM | Panel Discussion |
11:38 PM - 11:43 PM | Poster Award Presentation |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Saturday
SESSION 44:
TRIBUTE TO OUR MILITARY (5-MINUTE TALKS)
|
|
x | |
11:43 AM - 11:48 AM | From The Front Lines To The Ivory Tower And Back: How Advances At Walter Reed National Military Medical Center Are Used At The Front |
Presenter(s):Robert Craig, DO | |
11:49 AM - 11:54 AM | A Brief History Of The Tourniquet In Battle |
Presenter(s):Norman M. Rich, MD, FACS, DMCC | |
View Abstract | |
11:55 AM - 12:00 PM | Vascular Surgery Lessons Learned After A Decade Of War In Iraq And Afghanistan |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Saturday
SESSION 45:
LUNCHEON SESSION: NEW OR IMPROVED ENDOVASCULAR DEVICES (5-MINUTE TALKS)
Moderators:Eric L.G. Verhoeven, MD, PhD / Juan C. Parodi, MD
|
|
x | |
12:01 PM - 12:06 PM | Off-The-Shelf Fenestrated VENTANA Device For Renal Revascularization With Juxta And Pararenal AAAs: Clinical Update And Will In Situ Fenestration Be Possible With Newer Multilayer Stretchable PTFE Endograft Coverings |
Presenter(s):Daniel G. Clair, MD | |
12:07 PM - 12:12 PM | Recent Improvements In The Cook Zenith AAA Endograft: How Do They Make A Difference |
Presenter(s):Tara M. Mastracci, MD | |
12:13 PM - 12:18 PM | Update On Advantages And Limitations Of The Lombard AORFIX Graft: When Will It Be Approved In The US |
Presenter(s):Brian R. Hopkinson, ChM, FRCS / Mark F. Fillinger, MD | |
View Abstract | |
12:19 PM - 12:24 PM | Worldwide Experience With The Aptus HELIFX Endostaples: Can They Fix Endoleaks And Prevent Aortic Neck Enlargement And Migration |
Presenter(s):David H. Deaton, MD | |
12:25 PM - 12:30 PM | Update On The NELLIX Device For EVAR: Advantages And Limitations |
Presenter(s):Jeffrey P. Carpenter, MD | |
12:31 PM - 12:36 PM | Advantages And Limitations Of The INCRAFT From Cordis: 1-Year Clinical Data From The INNOVATION Trial |
Presenter(s):Gioacchino Coppi, MD / Dierk Scheinert, MD | |
12:37 PM - 12:42 PM | Description And Clinical Experience With The Anaconda Fenestrated Endograft For Juxta And Pararenal AAAs |
Presenter(s):Clark J. Zeebregts, MD, PhD | |
12:43 PM - 12:48 PM | Worldwide Mid-Term Results (2-Year) Of The Endurant Endograft For AAAs: Does It Expand The Proportion Of Patients Who Can Undergo EVAR Safely And Effectively |
Presenter(s):Dittmar Boeckler, MD / Michel S. Makaroun, MD | |
12:49 PM - 12:54 PM | Current Status Of The Bolton TREOVANCE AAA Endograft: Advantages And Limitations |
Presenter(s):Edward Y. Woo, MD / Ronald M. Fairman, MD | |
12:55 PM - 1:00 PM | Panel Discussion |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Saturday
SESSION 46:
ISSUES RELATED TO TRAINING, CERTIFICATION, SIMULATION, SPECIALTIES, GUIDELINES AND RANDOMIZED CONTROLLED TRIALS (5-MINUTE TALKS)
Moderators:Mario Lachat, MD / Karl A. Illig, MD
|
|
x | |
1:00 PM - 1:05 PM | What’s New With Maintenance Of Certification (MOC) Requirements For Vascular Surgeons |
Presenter(s):Anton N. Sidawy, MD, MPH | |
1:06 PM - 1:11 PM | Recent Developments In The Evolution Of Vascular Training And Training Programs: Current Status Of The 0:5 Programs And Number Of Vascular Surgery Applicants And Spots |
Presenter(s):Karl A. Illig, MD | |
1:12 PM - 1:17 PM | How To Redesign Workflow To Improve Patient Care And Resident Training |
Presenter(s):Richard J. Powell, MD | |
1:18 PM - 1:23 PM | Advantages Of Case Specific Simulator Rehearsal With Endovascular Procedures |
Presenter(s):Isabelle Van Herzeele, MD, PhD | |
1:24 PM - 1:29 PM | What’s New And Better With The Pontresina Vascular Surgery Simulator Course For Trainees |
Presenter(s):Hans-Henning Eckstein, MD, PhD | |
1:30 PM - 1:35 PM | Guidelines Are Outdated By The Time They Are Published: Some Examples |
Presenter(s):Janet T. Powell, MD, PhD | |
1:36 PM - 1:41 PM | Randomized Controlled Trials Can Be Misleading Even When Reported In Leading Journals: Guidelines Based On These Trials Can Also Be Misleading |
Presenter(s):Frank J. Veith, MD | |
1:42 PM - 1:47 PM | Advantages And Limitatons Of The OVATION Endograft (TriVascular) For AAA Repair: Based On The 1-Year Global Experience |
Presenter(s):Manish Mehta, MD, MPH | |
1:48 PM - 1:53 PM | Cost Effectiveness Of Different Treatment Strategies For CLI With Gangrene Or Necrosis |
Presenter(s):Michael Belkin, MD | |
View Abstract | |
1:54 PM - 2:00 PM | Panel Discussion |
END OF SESSION 46 | |
SESSION 47 SCHEDULE | |
Saturday
SESSION 47:
MORE ABOUT HEALTH CARE REFORM, FDA, ETHICS, COSTS, STANDARDS AND GUIDELINES (5-MINUTE TALKS)
Moderators:Kim J. Hodgson, MD / Thomas F. O'Donnell, Jr., MD
|
|
x | |
2:00 PM - 2:05 PM | Impact Of Obamacare On Medicine In The US |
Presenter(s):Clifford J. Buckley, MD / Shirley Buckley, RN | |
2:06 PM - 2:11 PM | Why The Canadian Health Care System Works Better Than Obamacare Will |
Presenter(s):Dheeraj Rajan, MD, FRCPC | |
View Abstract | |
2:12 PM - 2:17 PM | How Should Aviation Training Serve As A Model For Educating Vascular Surgeons |
Presenter(s):John F. Eidt, MD | |
2:18 PM - 2:23 PM | What Has And Will The FDA Do To Medical Innovation In The US: An FDA Consultant’s Perspective: Will Things Improve |
Presenter(s):Thomas J. Fogarty, MD | |
2:24 PM - 2:29 PM | What Is The FDA Doing To Help The US Device Industry Be More Competitive: Is It Working |
Presenter(s):Dorothy B. Abel, BSBME / Kenneth J. Cavanaugh, Jr., PhD | |
2:30 PM - 2:35 PM | How To Get A Physician-Sponsored IDE: Tips And Tricks |
Presenter(s):Benjamin W. Starnes, MD | |
2:36 PM - 2:41 PM | Advantages Of The ESVS (European Society For Vascular Surgery) Guidelines For Vascular Surgery: Some Examples As To Why They Are Better Than US Guidelines |
Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
2:42 PM - 2:47 PM | Current State Of The SVS Vascular Quality Initiative: Is It Growing And Is It Working |
Presenter(s):Jack L. Cronenwett, MD | |
2:48 PM - 2:53 PM | Vascular Quality Initiatives: A Dark Cloud Behind A Silver Lining: What Are Some Of The Problems And How Can They Be Resolved |
Presenter(s):Scott L. Stevens, MD | |
2:54 PM - 3:10 PM | Panel Discussion And Break Visit Pavilions and Exhibits (2nd and 3rd Floors). EXHIBITS CLOSE AT 3:15 P.M. |
END OF SESSION 47 | |
SESSION 48 SCHEDULE | |
Saturday
SESSION 48:
VASCULAR DISEASE NATURAL HISTORY; MEDICAL TREATMENT; PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators:Vivian Gahtan, MD / Peter F. Lawrence, MD
|
|
x | |
3:10 PM - 3:15 PM | New Developments In Anticoagulant Drugs For Vascular Patients |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
View Abstract | |
3:16 PM - 3:21 PM | Decision Making Tool For Determining Which CLI Treatment Is Best: Open vs. Endovascular |
Presenter(s):Darren B. Schneider, MD | |
3:22 PM - 3:27 PM | Ongoing Developments In Drug Treatment Of Vascular Disease: Do HDL Raising Drugs Show Promise For Preventing Strokes And MIs |
Presenter(s):Michael R. Jaff, DO / Ron Waksman, MD / Ido Weinberg, MD, MSc | |
3:28 PM - 3:33 PM | Role Of Optimal Medical Treatment In Stroke Prevention: Does It Really Work |
Presenter(s):Michael R. Jaff, DO / Ido Weinberg, MD, MSc | |
3:34 PM - 3:39 PM | DEBATE: The Truth About Statin Toxicity: Has It Been Overplayed By The FDA And By The Media |
Presenter(s):Bruce A. Perler, MD, MBA | |
3:40 PM - 3:45 PM | DEBATE: Statins May Be Harmful And Should Be Used Less |
Presenter(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
3:46 PM - 3:51 PM | How Should We Interpret The JUPITER Trial Showing The Value Of Statins: Has JUPITER Gotten A Bum Rap? |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
3:52 PM - 3:57 PM | Do L-Arginine Supplements Help Vascular Patients: When And How Should They Be Given |
Presenter(s):Vikram S. Kashyap, MD | |
View Abstract | |
3:58 PM - 4:03 PM | Carotid Glomectomy Is A Good Treatment For Syncopal Vasophlegia: How To Do It |
Presenter(s):Erik E. Debing, MD, PhD | |
View Abstract | |
4:04 PM - 4:09 PM | Interactive Telephone Program To Allow Daily Monitoring Of Vascular Patients |
Presenter(s):John (Jeb) W. Hallett, MD | |
4:10 PM - 4:15 PM | Comparative Performance Of Rotorex And Angiojet For Clot Removal From Lower Extremity Arteries: Advantages And Limitations Of Each |
Presenter(s):Hermann Steinkamp, MD | |
4:16 PM - 4:21 PM | A New Device To Treat Resistant Hypertension By Carotid Baroreceptor Stimulation: The BAROSTIM Trial |
Presenter(s):Fred A. Weaver, MD | |
View Abstract | |
4:22 PM - 4:29 PM | Routine Use Of Ultrasound Guidance And Micropuncture Makes Endovascular Access Safer: How To Do It |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
4:30 PM - 4:37 PM | Panel Discussion |
END OF SESSION 48 | |
SESSION 49 SCHEDULE | |
Saturday
SESSION 49:
NEW TECHNIQUES; NEW CONCEPTS (5-MINUTE TALKS)
Moderators:Alan B. Lumsden, MD, FACS / John J. Ricotta, MD
|
|
x | |
4:38 PM - 4:43 PM | Laparoscopic Treatment Of The Arcuate Ligament Syndrome: Technique, Indications And Results |
Presenter(s):Yves Alimi, MD | |
4:44 PM - 4:49 PM | Is There Still A Place For Unilateral And Even Bilateral Hypogastric Embolization In 2012: How Safe Is It |
Presenter(s):Dieter Raithel, MD, PhD | |
View Abstract | |
4:50 PM - 4:55 PM | Hypogastric Preservation In Patients With Common Iliac Aneurysms Using Off-The-Shelf Devices |
Presenter(s):Karthikeshwar Kasirajan, MD | |
4:56 PM - 5:01 PM | Unusual Causes Of Upper Extremity Arterial Occlusive Disease |
Presenter(s):Kenneth J. Cherry, MD | |
5:02 PM - 5:07 PM | Catheter Directed Prostaglandins Are An Effective Treatment For CLI: As The Sole Treatment Or As An Adjunct To Other Endovascular Therapy |
Presenter(s):Oscar L. Ojeda, MD / Marcelo Patero, MD | |
View Abstract | |
5:08 PM - 5:13 PM | Carotid Interventions For Acute Stroke: When Are They Worthwhile And When Are They Not |
Presenter(s):R. Clement Darling III, MD | |
View Abstract | |
5:14 PM - 5:19 PM | How Do Pericardial Patches Heal And Why Are They Likely To Resist Infection |
Presenter(s):Alan Dardik, MD, PhD | |
5:20 PM - 5:25 PM | Imaging And Endovascular Techniques In The Removal Of Transvenous Pacer And ICD Leads |
Presenter(s):Ali Khoynezhad, MD, PhD | |
View Abstract | |
5:26 PM - 5:31 PM | Update On Treatment Of Infected Abdominal And Thoracic Endografts: Is It A Solvable Or Hopeless Problem And Is Non-Excisional Treatment Ever Successful |
Presenter(s):Peter R. Taylor, MA, MChir, FRCS, ARCM | |
View Abstract | |
5:32 PM - 5:37 PM | Non-Atherosclerotic Aortic Thrombosis: Causes, Diagnosis And Treatment |
Presenter(s):Cynthia K. Shortell, MD | |
View Abstract | |
5:38 PM - 5:43 PM | The SoloPath Expandable Introducer Sheath: How Does It Work And How Can It Be Helpful In EVAR Procedures |
Presenter(s):Jeffrey P. Carpenter, MD | |
5:44 PM - 5:49 PM | Management Of Infected CEA Patches: A 10-Year Experience |
Presenter(s):Ali F. AbuRahma, MD | |
View Abstract | |
5:50 PM - 5:55 PM | In Situ Fenestration For Left Subclavian Revascularization During TEVAR Is Safer And Better Than Carotid Subclavian Bypass: How To Do It |
Presenter(s):Frank R. Arko, MD | |
5:56 PM - 6:01 PM | Bell Bottom Iliac Limbs Have A Downside |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
6:02 PM - 6:10 PM | Panel Discussion |
END OF SESSION 49 | |
SESSION 50 SCHEDULE | |
Saturday
SESSION 50:
UPDATES, NEW TECHNOLOGY, NEW CONCEPTS (5-MINUTE TALKS)
Moderators:Herbert Dardik, MD / Dhiraj M. Shah, MD
|
|
x | |
3:10 PM - 3:15 PM | Current Optimal Treatment Of Atrial Fibrillation In Vascular Patients |
Presenter(s):Jeffrey S. Berger, MD, MS, FAHA, FACC | |
3:16 PM - 3:21 PM | Prevalence Of Carotid Stenosis Varies According To Race: Highest In Caucasians And Native Americans |
Presenter(s):Caron B. Rockman, MD | |
3:22 PM - 3:27 PM | Ehrlos-Danlos Patients Can Have Endovascular Procedures Performed Safely: What Precautions Are Needed |
Presenter(s):James H. Black III, MD | |
3:28 PM - 3:33 PM | Bioabsorbable Scaffolds (REMEDY Stent), DEBs And DESs, In The SFA: What Is Their Future |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
3:34 PM - 3:39 PM | Can The Achilles Tendon Be Excised Safely And With Minimal Disability To Treat Bad Heel Wounds And Plantar Pedal Ulcers |
Presenter(s):Wayne Caputo, DPM / Clifford M. Sales, MD, MBA | |
3:40 PM - 3:45 PM | Drug Eluting Balloon Evaluation For Lower Limb Multilevel Treatment – DEBELLUM Trial: 1-Year Results |
Presenter(s):Fabrizio Fanelli, MD / Plinio Rossi, MD | |
3:46 PM - 3:51 PM | Bypasses For Hand Digital Ischemia: What Is Their Role And Their Results |
Presenter(s):R. Clement Darling III, MD | |
View Abstract | |
3:52 PM - 3:57 PM | Retrohepatic Balloon Occlusion Of The IVC For Trauma And Renal Cell Cancer: How To Do It With Current Technology |
Presenter(s):Joseph S. Giglia, MD | |
3:58 PM - 4:03 PM | Carotid-To-Axillary Bypass Is Useful As A Debranching Technique And Easier And Less Risky Than Carotid-To-Subclavian Bypass |
Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
4:04 PM - 4:09 PM | VIATORR Covered Stent For Early TIPS And Its Effect On Hepatic Encephalopathy And Ascites: Other New Horizons In TIPS |
Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
4:10 PM - 4:15 PM | Which Post EVAR Patients Need Minimal Follow-up Surveillance: What Should That Consist Of |
Presenter(s):Hence J.M. Verhagen, MD, PhD | |
4:16 PM - 4:21 PM | Angioslide Angioplasty Balloon With Embolic Capture (Proteus Device): When To Use It And Evidence Of Effectiveness |
Presenter(s):Peter C.J. Goverde, MD | |
4:22 PM - 4:27 PM | Outcomes Of Endovascular Treatment Of Lower Extremity Lesions Are Worse In Young Patients (<50) |
Presenter(s):Rabih A. Chaer, MD | |
4:28 PM - 4:34 PM | Panel Discussion |
END OF SESSION 50 | |
SESSION 51 SCHEDULE | |
Saturday
SESSION 51:
MORE NEW CONCEPTS, UPDATES AND NEW TECHNIQUES (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Palma M. Shaw, MD
|
|
x | |
4:34 PM - 4:39 PM | Limitations Of A Large Palmaz Stent For Treating Type I Endoleaks |
Presenter(s):Tilo Koelbel, MD, PhD | |
4:40 PM - 4:45 PM | Recent Volumetric Analyses Of Post EVAR AAA Sac Behavior: Is Sac Enlargement Still A Concern |
Presenter(s):Mark F. Fillinger, MD | |
4:46 PM - 4:51 PM | 2-Stage Treatment For Aorto-Enteric Fistulas Following Aortic Reconstruction: A New Better Way |
Presenter(s):Gioacchino Coppi, MD | |
4:52 PM - 4:57 PM | Siena Score For Evaluating AAAs Suitability For EVAR: What Is It And How Does It Help |
Presenter(s):Francesco Setacci, MD | |
View Abstract | |
4:58 PM - 5:03 PM | Advantages And Early Results Of The ALTURA Ultra Low Profile AAA Endograft |
Presenter(s):Albrecht H. Kramer, MD | |
5:04 PM - 5:09 PM | Fascial Suture To Close Large Percutaneous Sheath Insertion Sites Cheaply And Effectively (The Larzon Technique): Tips And Tricks |
Presenter(s):Timothy A. Resch, MD, PhD | |
5:10 PM - 5:15 PM | Cost Per Day Of Patency In Endo vs. Open Lower Extremity Revascularization Procedures |
Presenter(s):Manish Mehta, MD, MPH | |
5:16 PM - 5:21 PM | Current Status Of Silver Impregnated Grafts To Treat Aortic Infection: Are We In The US Being Denied A Valuable Treatment Adjunct |
Presenter(s):Max Zegelman, MD, PhD | |
View Abstract | |
5:22 PM - 5:27 PM | Antibiotic Drug Delivery Implants Facilitates Treatment Of Some Infected Vascular Prosthetic Grafts |
Presenter(s):Dennis F. Bandyk, MD | |
5:28 PM - 5:33 PM | DW-MRI Based Evidence That Interruption Of Flow Embolic Protection With The MoMa Device Is Effective During CAS (The DESERVE Trial) |
Presenter(s):Giancarlo Biamino, MD, PhD | |
5:34 PM - 5:39 PM | Optimal Current Use Of Anticoagulants And Antiplatelet Drugs In Patients Undergoing CEA |
Presenter(s):Timothy M. Sullivan, MD | |
5:40 PM - 5:45 PM | Causes And Implications Of 30-Day Readmissions After AAA Repair: Endo And Open |
Presenter(s):K. Craig Kent, MD | |
5:46 PM - 5:51 PM | BASIL Survival Prediction Model In Patients With CLI: Validation And Comparison With PREVENT And FINNUVASC Scores |
Presenter(s):Robert J. Hinchliffe, MD | |
5:52 PM - 5:57 PM | Importance Of Pressure Gradients In Assessing Hemodynamic Significant Vascular Lesions: A Simple Method To Measure Them |
Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
5:58 PM - 6:05 PM | Panel Discussion |
END OF SESSION 51 | |
Sunday, November 18, 2012
Print Entire 2012 Program:
|
|
SESSION 52 SCHEDULE | |
Sunday
SESSION 52:
NEW DEVELOPMENTS AND UPDATES: EARLY CAROTID TREATMENT, TAKAYASU’S DISEASE AND TECHNIQUES FOR EVALUATING CAROTID PLAQUES NONINVASIVELY (5-MINUTE TALKS)
Moderators:Frans L. Moll, MD, PhD / Lucien D. Castellani, MD
|
|
x | |
6:40 AM - 6:45 AM | Techniques For Crossing Over Difficult Aortic Bifurcations To Deliver Contralateral Interventions |
Presenter(s):Scott L. Stevens, MD | |
6:46 AM - 6:51 AM | Outcomes Of Urgent CEA In Symptomatic Patients: Are They Acceptable |
Presenter(s):Gabriel Szendro, MD | |
View Abstract | |
6:52 AM - 6:57 AM | Can The 14-Day Treatment Target For Symptomatic Carotid Disease Patients Be Met: Are The Outcomes Acceptable |
Presenter(s):A. Ross Naylor, MD, FRCS | |
6:58 AM - 7:03 AM | Results Of Urgent CEA In Symptomatic Patients: Can CAS Results Equal Them |
Presenter(s):Laura Capoccia, MD, PhD | |
View Abstract | |
7:04 AM - 7:09 AM | Is Early Intervention For Symptomatic Carotid Stenosis As Good For CAS As CEA |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
7:10 AM - 7:15 AM | How To Treat Cerebral Ischemia From Takayasu’s Disease |
Presenter(s):Zhong Gao Wang, MD | |
View Abstract | |
7:16 AM - 7:21 AM | When Is Endovascular Treatment Of Takayasu’s With PTA, Stent Or Stent-Graft Indicated And Justified By The Results |
Presenter(s):Xiaoyun Luo, MD | |
7:22 AM - 7:27 AM | Pros And Cons Of Open Bypass Surgery And Endovascular Procedures With Supra-aortic Lesions Due To Takayasu’s Disease |
Presenter(s):Young Wook Kim, MD | |
View Abstract | |
7:28 AM - 7:33 AM | Panel Discussion |
Moderator(s): Thomas S. Riles, MD / Allan L. Brook, MD | |
7:34 AM - 7:39 AM | DEBATE: Key Findings In The SAMMPRIS Trial Showing Intracranial Stents To Be Less Effective Than Best Medical Treatment In Preventing Strokes |
Presenter(s):Colin P. Derdeyn, MD | |
7:40 AM - 7:45 AM | DEBATE: SAMMPRIS Had Major Flaws And Reached Misleading Conclusions |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
7:46 AM - 7:51 AM | How To Make Endovascular Treatment Of Acute Strokes Work Best In 2012: Why Have Some Of The Trials To Date Been Negative |
Presenter(s):Don Frei, MD | |
7:52 AM - 7:57 AM | Relationship Between IVUS-Characterized Plaque Morphology And Embolic Potential – Spontaneously And During CAS |
Presenter(s):Wei Zhou, MD | |
7:58 AM - 8:03 AM | Dynamic Contrast Ultrasonography To Stratify Risk In Asymptomatic Carotid Stenosis Patients: How Does It Work |
Presenter(s):Alun H. Davies, MA, DM, FRCS, FHEA, FEBVS, FACPh | |
View Abstract | |
8:04 AM - 8:09 AM | 3-D Ultrasound And MRI Assessment Of Carotid Plaques: Do Statins Result In Plaque Shrinkage And Other Beneficial Changes |
Presenter(s):Henrik Sillesen, MD, DMSc | |
View Abstract | |
8:10 AM - 8:15 AM | How To Identify Asymptomatic Carotid Stenoses At High Risk For Causing A Stroke: Searching For The Holy Grail |
Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS | |
8:16 AM - 8:21 AM | Impact Of Contralateral Carotid Occlusion (CCO) On The Comparative Results Of CEA And CAS For Treatment Of Carotid Stenosis: CAS Is Equivalent To CEA With CCO |
Presenter(s):Joseph J. Ricotta II, MD, MS / Gilbert R. Upchurch, MD / Gregg S. Landis, MD | |
8:22 AM - 8:28 AM | Panel Discussion |
END OF SESSION 52 | |
SESSION 53 SCHEDULE | |
Sunday
SESSION 53:
MORE ABOUT THORACIC AND ABDOMINAL ANEURYSMS: MANAGEMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators:K. Wayne Johnston, MD, FRCS / Larry H. Hollier, MD
|
|
x | |
8:28 AM - 8:33 AM | Current Treatment Of Para-anastomotic Aneurysms After Open Surgery: Are They Easily Fixed Endovascularly |
Presenter(s):Arno von Ristow, MD | |
View Abstract | |
8:34 AM - 8:39 AM | Endovascular Treatment Of Late Complications From Open AAA Surgery |
Presenter(s):Giancarlo Mansueto, MD | |
8:40 AM - 8:45 AM | MRI Is Better Than CTA For Finding Endoleaks And Identifying Their Type: Why |
Presenter(s):Frans L. Moll, MD, PhD | |
8:46 AM - 8:51 AM | EVAR Of Primary Infected (Mycotic) AAAs: Results Are Surprisingly Good But Not Universally So |
Presenter(s):Anders Wanhainen, MD, PhD / Martin Bjorck, MD, PhD | |
8:52 AM - 8:57 AM | Techniques For Safe Open Conversion After Failed EVAR And TEVAR |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD | |
View Abstract | |
8:58 AM - 9:03 AM | Complications Of TEVAR For Treatment Of Traumatic Aortic Injury And How They Can Be Prevented And Treated |
Presenter(s):Ali Azizzadeh, MD | |
9:04 AM - 9:09 AM | How To Treat AAAs With <14 mm Distal Necks Safely With Bifurcated Endografts |
Presenter(s):Gustavo S. Oderich, MD, FACS | |
9:10 AM - 9:15 AM | Cost Effectiveness Of EVAR And Open Repair In The OVER Trial After 2 Years |
Presenter(s):Frank A. Lederle, MD | |
9:16 AM - 9:21 AM | Thoracic Aortic Aneurysm In Patients With AAAs: How Common Are They And When Should They Be Looked For With Chest CT |
Presenter(s):Rabih A. Chaer, MD / Michel S. Makaroun, MD | |
9:22 AM - 9:27 AM | When Are Custom Made Endografts Needed To Treat Thoracic Aneurysm Pathology |
Presenter(s):Vicente Riambau, MD, PhD | |
View Abstract | |
9:28 AM - 9:33 AM | Limb Component Issues With Newer Lower Profile EVAR Devices: Will They Be A Problem |
Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
9:34 AM - 9:39 AM | Are There Still Indications For Hybrid Procedures for TAAA/Repair |
Presenter(s):Ian Loftus, MD | |
9:40 AM - 9:45 AM | Present Status Of Intrasac Pressure Measurements With The CardioMEMS Device In The Management Of Endoleaks: Is It Worthwhile And Worth The Cost |
Presenter(s):Ross Milner, MD | |
9:46 AM - 10:00 AM | Panel Discussion And Break Coffee Available in Grand Ballroom Foyer, 3rd Floor |
END OF SESSION 53 | |
SESSION 54 SCHEDULE | |
Sunday
SESSION 54:
NEW DEVELOPMENTS IN CAROTID DISEASE TREATMENT AND ASSOCIATED ISSUES (5-MINUTE TALKS)
Moderators:Hans-Henning Eckstein, MD, PhD / John B. Chang, MD
|
|
x | |
10:00 AM - 10:05 AM | A Postop MI With Only A Rise In Troponin Is A Bad Thing But No Worse A Predictor Of Late Mortality Than Any Stroke: Based On CREST And Other Data |
Presenter(s):Wesley S. Moore, MD | |
View Abstract | |
10:06 AM - 10:11 AM | When Do Clot Retrieval Devices Work In Acute Stroke: Which Device Is Best – Merci, Penumbra, Solitaire And Trevo: The SWIFT Trial |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
10:12 AM - 10:17 AM | CAS Or CEA For Carotid Disease Associated With Neck Radiation: Which Treatment Is Best |
Presenter(s):Frans L. Moll, MD, PhD | |
10:18 AM - 10:23 AM | Value And Limitation Of Optical Coherence Tomography To Evaluate Carotid Plaques And Luminal Anatomy Before And After CAS |
Presenter(s):Carlo Setacci, MD | |
10:24 AM - 10:29 AM | Simplified Safe Technique For Carotid Subclavian Bypass |
Presenter(s):Ramon Berguer, MD, PhD / Mark D. Morasch, MD, FACS, RPVI | |
View Abstract | |
10:30 AM - 10:35 AM | DEBATE: When Should A Shunt Be Used During CEA: From The VSGNE |
Presenter(s):Philip P. Goodney, MD, MS / Jack L. Cronenwett, MD | |
View Abstract | |
10:36 AM - 10:41 AM | DEBATE: A Shunt Should Never Be Used During CEA: What Is Required To Use The No-Shunt Technique Safely |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
10:42 AM - 10:47 AM | Panel Discussion |
Moderator(s): Benjamin W. Starnes, MD / Thomas S. Riles, MD | |
10:48 AM - 10:53 AM | Technical Tricks And Devices Make CAS Easier And Safer With The MoMa Flow Cessation Device And The 2 Wire PITON Catheter |
Presenter(s):Gioacchino Coppi, MD | |
10:54 AM - 10:59 AM | How To Risk Adjust Symptomatic And Asymptomatic Patients For CAS And CEA: A View Of A Vascular Specialist Who Does Both |
Presenter(s):Jon S. Matsumura, MD | |
11:00 AM - 11:05 AM | The Case Against Routine Carotid Patching Despite All The Level I Evidence And Hype: How And When To Avoid Patches |
Presenter(s):Glenn M. LaMuraglia, MD | |
11:06 AM - 11:11 AM | Endovascular Treatment And Bailout Of Complications From Carotid Surgery: A Simpler Better Solution Than Redo Surgery |
Presenter(s):Franco Grego, MD / Giovanni P. Deriu, MD | |
11:12 AM - 11:17 AM | A New Better Monitoring Technique For CEA: Light General/Endotracheal Anesthesia Which Allows Patients To Demonstrate Motor Function: It Really Works And Decreases Patient And Surgeon Stress |
Presenter(s):Giancarlo G.C. Accarino, MD | |
11:18 AM - 11:23 AM | PTFE Interposition Grafts For CEA Gone Wrong: An Effective And Durable Bailout Procedure |
Presenter(s):Dieter Raithel, MD, PhD | |
View Abstract | |
11:24 AM - 11:29 AM | DEBATE: AHA And European Cardiology Guidelines For CAS Have It Right: CAS Is An Alternative To CEA For Symptomatic Patients With Carotid Stenosis |
Presenter(s):Alberto Cremonesi, MD, FESC | |
11:30 AM - 11:35 AM | DEBATE:Nonsense: The SVS Guidelines Have It Right: CAS Is Not An Alternative To CEA For Most Symptomatic Patients With Carotid Stenosis |
Presenter(s):Michel S. Makaroun, MD | |
11:36 AM - 11:42 AM | Panel Discussion |
END OF SESSION 54 | |
SESSION 55 SCHEDULE | |
Sunday
SESSION 55:
NEW DEVELOPMENTS AND CONTROVERSIAL ISSUES RELATED TO CAS AND CEA (5-MINUTE TALKS)
Moderators:Peter A. Schneider, MD / Frank J. Veith, MD
|
|
x | |
11:42 AM - 11:47 AM | Comparison Of 5 Different Guidelines For Treating Carotid Stenosis: How Can Such Differing Interpretations Be Drawn From The Same Data |
Presenter(s):Kosmas I. Paraskevas, MD / Dimitri P. Mikhailidis, MD / Frank J. Veith, MD | |
View Abstract | |
11:48 AM - 11:53 AM | CREST Cost Comparisons Between CAS And CEA: Possible Flaws In The CREST Cost Data That Make Its Conclusions Misleading |
Presenter(s):W. Charles Sternbergh III, MD | |
11:54 AM - 11:59 AM | Impact Of Cranial Nerve Defects (CRI) In CREST At One Year: These CRIs Were Minor And Not Equivalent To Strokes |
Presenter(s):Thomas G. Brott, MD | |
12:00 PM - 12:05 PM | DEBATE: CEA vs. CAS In Symptomatic Patients: The Heart Should Not Rule The Head When Deciding Treatment Strategies |
Presenter(s):A. Ross Naylor, MD, FRCS | |
12:06 PM - 12:11 PM | DEBATE: CEA vs. CAS In Symptomatic Patients: The Heart Should Rule The Head When Deciding Treatment Strategies |
Presenter(s):Peter A. Schneider, MD | |
View Abstract | |
12:12 PM - 12:17 PM | Which Carotid Patients Needing Invasive Treatment Do I Currently Send For CEA |
Presenter(s):Klaus D. Mathias, MD | |
12:18 PM - 12:23 PM | Are CAS vs. CEA Trials Inherently Biased: Critical Appraisal Of Endpoints |
Presenter(s):Timothy M. Sullivan, MD | |
12:24 PM - 12:29 PM | DEBATE: Many Selected Asymptomatic Carotid Stenosis Patients Benefit From CEA: How Should They Be Picked |
Presenter(s):Bruce A. Perler, MD, MBA | |
View Abstract | |
12:30 PM - 12:35 PM | DEBATE: Not So: With Asymptomatic Carotid Stenosis Patients Any Benefit Of Invasive Treatment Is Outweighed By The Risks |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP, FRACP | |
View Abstract | |
12:36 PM - 12:41 PM | Predictors Of Early Adverse Outcomes After CEA: Are They An Indication For CAS |
Presenter(s):Erik E. Debing, MD, PhD | |
View Abstract | |
12:42 PM - 12:47 PM | Current Strategies For Treating Carotid And Vertebral Dissections |
Presenter(s):L. Nelson Hopkins, MD | |
View Abstract | |
12:48 PM - 12:53 PM | Is A Postop MI With Only A Rise In Troponin A Bad Thing And Predictive Of Late Increased Mortality Risk |
Presenter(s):Andres Schanzer, MD | |
12:54 PM - 12:59 PM | Current Stent Design For CAS Procedures Is Inadequate: What Is On The Horizon To Remedy This |
Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
1:00 PM - 1:20 PM | Panel Discussion Lunch Available in the Grand Ballroom |
END OF SESSION 55 | |
SESSION 56 SCHEDULE | |
Sunday
SESSION 56:
NEW HORIZONS, NEW CONCEPTS AND LATE BREAKING DEVELOPMENTS (5-MINUTE TALKS)
Moderators:John E. Connolly, MD / Enrico Ascher, MD
|
|
x | |
1:20 PM - 1:25 PM | Endovascular Conversion Of Open Surgical Failures And Complications: Tips And Tricks |
Presenter(s):Jos C. van den Berg, MD, PhD | |
1:26 PM - 1:31 PM | Technique Of Balloon Common Iliac Occlusion To Facilitate Antegrade Wire Passage Through Flush Iliac Occlusions: A Cheaper Safer Way |
Presenter(s):Peter H. Lin, MD | |
1:32 PM - 1:37 PM | Novel Technique For Treating Type II Endoleaks By Accessing AAA Sac And Nidus Via Distal Endograft Attachment Site |
Presenter(s):Gioacchino Coppi, MD | |
1:38 PM - 1:43 PM | What Happens When SFA And Poplilteal Stents Fail |
Presenter(s):Vincent L. Rowe, MD / Steven G. Katz, MD | |
View Abstract | |
1:44 PM - 1:49 PM | CFA Stenting Can Be Done Safely And Effectively In An Outpatient Setting: Tips And Tricks |
Presenter(s):Sam S. Ahn, MD, MBA, FACS | |
1:50 PM - 1:55 PM | Results Of The DUET Trial: A RCT Comparing Ultrasound Enhanced vs. Standard Thrombolysis For Arterial Occlusions |
Presenter(s):Jean-Paul de Vries, MD, PhD | |
1:56 PM - 2:01 PM | Xenograft Pericardial Tubes And Radical Debridement Of Surrounding Tissues: A New Concept For Treating Prosthetic Graft Infections |
Presenter(s):Jürg Schmidli, MD | |
2:02 PM - 2:07 PM | Current Optimal Treatment Of Carotid And Vertebral Spontaneous And Traumatic Dissections |
Presenter(s):Irwin V. Mohan, MD, FRCS, FEBVS, FRACS | |
View Abstract | |
2:08 PM - 2:13 PM | Update On The SETA Balloon Expandable AAA Endograft: Mid-Term Clinical Experience |
Presenter(s):Hernan G. Bertoni, MD | |
2:14 PM - 2:19 PM | Panel Discussion |
Moderator(s): James F. McKinsey, MD / Lucien D. Castellani, MD | |
2:20 PM - 2:25 PM | Open Aortic Repair After Failed EVAR: Tips And Tricks To Lower Morbidity And Mortality |
Presenter(s):R. Clement Darling III, MD | |
View Abstract | |
2:26 PM - 2:31 PM | Crossing Lower Extremity CTOs Using The VIANCE And ENTEER Devices: Final Results Of The PFAST Trial |
Presenter(s):Subhash Banerjee, MD | |
2:32 PM - 2:37 PM | Endovascular Techniques For Carotid And Cerebral Artery Thrombectomy For Acute Stroke: Experience In >130 Patients |
Presenter(s):Klaus D. Mathias, MD | |
2:38 PM - 2:43 PM | Interventions Performed Within 1 Week Of A Neurological Event: Outcomes O CEA Are Better Than CAS (Data From The EVA-3S, The SPACE And The ICSS Trials) |
Presenter(s):Gustav Fraedrich, MD / Barbara Rantner, MD / Georg Goebel, MD / Leo H. Bonati, MD | |
View Abstract | |
2:44 PM - 2:49 PM | How Was CREST Data Presented In The FDA Application For Low Risk Carotid Stenting In A Way That Renders Them Misleading |
Presenter(s):Thomas G. Brott, MD | |
2:50 PM - 2:55 PM | Filters vs. Flow Reversal And Occlusion: Advantages And Disadvantages Of Both |
Presenter(s):Claudio J. Schonholz, MD | |
2:56 PM - 3:01 PM | SVS Registry Results Show CEA To Have Superior Outcomes To Those Of CAS In Symptomatic And Asymptomatic Patients Over 65 |
Presenter(s):Brian G. Rubin, MD | |
View Abstract | |
3:02 PM - 3:07 PM | Can Medical Treatments Decrease AAA Growth Rates: Prospects For The Future |
Presenter(s):Russell H. Samson, MD, RVT, FACS | |
3:08 PM - 3:13 PM | Comparative Outcomes Of Bell Bottom Technique And Hypogastric Exclusion For Common Iliac Aneurysms Treated By EVAR: Bell Bottom Wins |
Presenter(s):Mark K. Eskandari, MD | |
View Abstract | |
3:14 PM - 3:21 PM | Panel Discussion |
END OF SESSION 56 | |
SESSION 57 SCHEDULE | |
Sunday
SESSION 57:
LATE BREAKING TOPICS OF PARTICULAR INTEREST (5-MINUTE TALKS)
Moderators:Kenneth Ouriel, MD, MBA, FACS, FACC / Frank J. Veith, MD
|
|
x | |
3:21 PM - 3:26 PM | 4-Year Results With Sandwich Technique For Treating Common And Internal Iliac Aneurysms |
Presenter(s):Armando C. Lobato, MD, PhD | |
3:27 PM - 3:32 PM | Iliac Branched Devices Work Well In Worldwide Experience: The PRESERVE Trial |
Presenter(s):W. Anthony Lee, MD | |
3:33 PM - 3:38 PM | Infected AAAs: Endovascular Therapy Should Be The First Choice: How To Make It Work With 2-6 Years Follow-up |
Presenter(s):Boonprasit Kritpracha, MD | |
3:39 PM - 3:44 PM | Proportion Of CLI Patients Requiring Open Surgery When Endo Is The First And Favored Option: A Totally Endo First Strategy May Not Be Cost Effective |
Presenter(s):Firas F. Mussa, MD | |
3:45 PM - 3:50 PM | Flow Control To Prevent Embolic Complications During Endovascular Treatment Of Aortoiliac Occlusive Disease |
Presenter(s):Claudio J. Schonholz, MD | |
3:51 PM - 3:56 PM | Treatment Of Refractory Post-Thrombotic Syndrome By Cutting Balloon Angioplasty Of The Popliteal Vein |
Presenter(s):Thomas O. McNamara, MD | |
3:57 PM - 4:02 PM | Military Translational Research To Develop A New Fluoroscopy-Free Endovascular Balloon Occlusion System To Treat End-Stage Shock |
Presenter(s):Todd E. Rasmussen, MD, FACS | |
4:03 PM - 4:08 PM | Double Chimney Technique To Treat Arch Aneurysms: How To Make Them Work |
Presenter(s):Jan S. Brunkwall, MD, PhD | |
4:09 PM - 4:14 PM | Endovascular Graft Treatment Of Popliteal Aneurysms Is As Effective As Open Surgery In Terms Of Long- Term Patency |
Presenter(s):Michel S. Makaroun, MD / Rabih A. Chaer, MD | |
4:15 PM - 4:20 PM | Panel Discussion |
4:20 PM - 4:25 PM | Raffle Drawing – You Must Be Present To Win |
4:25 PM - 4:25 PM | Symposium Ends Save The Date For 2013: November 20-24, 2013 at the Hilton New York |
END OF SESSION 57 | |